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1. Introduction 
 
Mammalian cells respond to interferons (IFNs) by the transcriptional upregulation of 
more than a thousand genes. Surprisingly, among those genes many of the most 
abundantly induced proteins are GTPases. For instance, immunity-related GTPases 
(IRG) were discovered because of their massive induced-expression in response to 
IFN-γ. Later on it turned out that many members of IRG proteins play indispensable 
roles in IFN-orchestrated intracellular anti-pathogen programs. Therefore it is totally 
logical that the expression of IRGs should be under the tight control of IFNs, as has 
also been proved by many reports. Unexpectedly, however, we found that IRG 
proteins do have constitutive expression in many mouse tissues. Despite of this tissue 
specific expression, our attention was then attracted by well-defined intense focal 
expression of IRG proteins in liver and kidney. Interestingly, this focal expression, 
which was exclusively IFN dependent, turned out to be related to local activation of 
NKT cells. In the following introduction, I will first describe the IFN system before 
give the depiction of IRG proteins, and finally a description of NKT cells will be 
presented.  
 
1.1. Interferons 
Interferons (IFNs) are a family of structurally related cytokines discovered because of 
their hallmark function of antiviral activity, and are found only in vertebrates (Isaacs 
and Lindenmann, 1957; Wheelock, 1965). Despite their distinct antiviral activates, 
IFNs exhibit a diversity of biological functions, such as cell proliferation or 
immunomodulatory effects.  
 
1.1.1 Three types of interferons 
IFNs consist of several types namely type I, II and III IFNs. The type I IFNs 
(MacMicking et al., 2003; Martens and Howard, 2006; Roberts et al., 1998) consist of 
IFN-α, -β, -ω, -ε (Langer et al., 2004; Pestka et al., 2004) and –κ (LaFleur et al., 
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2001). All these members are massively induced in virus-infected cells. Type I IFNs, 
IFN-α/β play a vital role in innate resistance to a wide variety of viruses through the 
induction of antiviral effects, both directly and indirectly, e.g. up-regulation of iNOS, 
Mx, PKR, 2’-5’ oligoadenylate synthetase, MHC molecules etc. (Taylor et al., 2000; 
Theofilopoulos et al., 2005). IFN-α/β also has an immunomodulatory effect of 
activating natural killer (NK) cells, macrophages both of which are essential effector 
cells in the innate immune system (Biron et al., 1999; Taylor et al., 2004; 
Theofilopoulos et al., 2005). In addition, by virtue of their potentiating effect on DC 
maturation, type I IFNs are currently recognized as pivotal cytokines bridging two 
aspects of host defence, innate and adaptive immune systems (Banchereau and 
Steinman, 1998). 
Type II IFN comprises solely IFN-γ (Ikeda et al., 2002). Even though IFN-γ has 
similar antiviral activity and thereby is defined as an interferon, this cytokine is 
strongly produced not by virus infected cells, rather by activated NK cells (Perussia, 
1991), activated T helper cells of the Th1 subset (Mosmann and Coffman, 1989), and 
activated CD8 cytotoxic cells (Sad et al., 1995). In T cells the main inducer of IFN-γ 
is cross-linking of the T cell receptor (Ullman et al., 1990), whereas in NK cells, 
IFN-γ production is stimulated by macrophage-derived cytokines, especially TNF-α 
and IL-12 (Trinchieri, 1995) and is stimulate by IFN-γ itself (Hardy and Sawada, 
1989). IFN-γ has direct antiviral effects partially overlapping that of type I IFNs by 
up-regulation of antiviral effectors like PKR, 2’-5’ oligoadenylate synthetase, dsRAD 
(Beretta et al., 1996; Patterson et al., 1995). Nevertheless, the antiviral responses of 
IFN-γ are not completely the same as type I IFNs, for instance, anti-viral GTPase, Mx 
is solely induced by type I IFNs. IFN-γ, in addition to its antiviral function, is 
essential for the elimination of intracellular microorganisms through the activation of 
macrophages accompanied by the release of reduced oxygen intermediates. This is 
achieved by up-regulation of genes like gp91-phox, iNOS, and NRAMP (Baek et al., 
1993; Cassatella et al., 1989; Govoni et al., 1995). Despite its complex responses in 
innate immunity, IFN-γ is involved in immunoregulatory action such as synergism 
and antagonism with pivot cytokines like IL-12 or IL-4, the Th phenotype 
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determination, and antigen presentation pathway (Lehn et al., 1989; Ma et al., 1996; 
Rousset et al., 1988; Seder and Paul, 1994; Trinchieri, 1995).  
Newly identified IFN members, IFN-λs or IL-28/29 are similar to type I IFNs, and 
they are induced upon viral infection and exert similar antiviral functions (Kotenko et 
al., 2003; Sheppard et al., 2003; Vilcek, 2003). However, the major differences are 
that they are structurally distinct from type I IFNs and that they utilize their specific 
receptor subunit, IFN-λR1 or IL-28Rα and IL-10R2, nevertheless the signaling 
pathways appear to be shared with type I interferons. And interestingly Mx1 was 
shown to be able to be induced by IFN-λs. 
 
1.1.2 Signaling pathways activated by IFNs 
All IFN-α/β subtypes interact with the same receptor complex, termed the IFN-α/β 
receptor (IFNAR), which consists of at least two subunits, IFNAR-1 and IFNAR-2 
(Darnell et al., 1994; Novick et al., 1994; Stark et al., 1998; Uze et al., 1990) (Fig. 1). 
The intracellular domains of these two subunits, IFNAR-1 and IFNAR-2, are 
associated with Janus protein tyrosine kinases (Jak PTKs), Tyk2 and Jak1 respectively. 
As for type II IFN signaling, IFN-γ binds to the IFN-γ receptor complex (IFNGR), 
comprising IFNGR-1 and IFNGR-2; the IFNGR1 subunit is constitutively associated 
with Jak1, whereas IFNGR2 with Jak2 (Bach et al., 1997; Chen et al., 2004; Stark et 
al., 1998). The binding of both types of IFNs to IFNAR or IFNGR results in the 
cross-activation of these Jak protein kinases, which then phosphorylate their 
downstream substrates, Stat1 and Stat2 (signal transducers and activators of 
transcription) (Darnell et al., 1994; Ihle and Kerr, 1995; Schindler and Darnell, 1995; 
Stark et al., 1998), causing the formation of STAT1-STAT2 heterodimers for type I 
IFNs, and STAT1 homodimers for IFN-γ. Thereafter, STAT1-STAT2 heterodimers 
associate with a third protein, IRF9, and bind one class of type I IFN response 
elements, the ISRE, whereas STAT1 homodimers activate gene expression by binding 
to another class of IFN response elements, the GAS (Bluyssen et al., 1996; Darnell et 
al., 1994; Decker et al., 1991; Haque and Williams, 1994; Lew et al., 1991). 
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IFN-λ bind their receptors IFN-λR1 and IL-10R2 on the cell surface and signal also 
Figure 1. IFNs signaling pathways. IFN-αβ (type I IFNs) and IFN-γ (type II IFN) bind to specific 
and distinct heterodimeric receptors. Binding of IFN-α or IFN-β to their receptor leads to the 
activation of two receptor-associated tyrosine kinases, Jak1 and Tyk2; this is followed by tyrosine 
phosphorylation of the STAT1 and STAT2 proteins. Phosphorylated STAT1 and STAT2 combine 
with IRF-9 (IFN-regulatory factor 9) to form the trimeric ISGF-3 complex, which, upon 
translocation to the nucleus, binds to the cis element ISRE (IFN-stimulated response element), 
which is present in most IFN-α and IFN-β−responsive genes. In contrast, binding of IFN-γ to its 
receptor leads to tyrosine phosphorylation of the Jak1 and Jak2 tyrosine kinases, resulting in the 
phosphorylation of STAT1 but not STAT2. Phosphorylated STAT1 homodimerizes to form the 
GAF-AAF complex, which translocates to the nucleus and binds to the IFN- activation site (GAS) 
element present in most IFN-γ−inducible genes. Like IFN-γ, IFN-α and IFN-β signaling can also 
lead to the formation of the GAF-AAF complex and its binding to the GAS regulatory element. 
The three newly identified IFN-λ proteins (also termed IL-28A, IL-28B and IL-29) bind to a 
heterodimeric receptor composed of a previously unknown IFN-R1 subunit and IL-10R2, which 
also serves as the second chain of the IL-10R. Although the tyrosine kinases activated by IFN-λ 
have not yet been identified, available evidence indicates that both STAT1 and STAT2 are 
activated and the downstream signaling pathways activated by IFN-λ appear to be indistinguishable 
from those activated by IFN-α and IFN-β. (Vilcek, 2003). 
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through unidentified Jak kinases. Similar to type I IFN signaling, IFN-λ receptor 
clustering leads to the activation of both STAT1 and STAT2 (Kotenko et al., 2003; 
Sheppard et al., 2003; Vilcek, 2003). 
 
1.2. Interferon inducible GTPases 
During infection, mammalian cells respond to interferons (IFNs) by the 
transcriptional upregulation of more than a thousand genes, among which many of the 
most abundantly induced proteins are GTPases e.g. Mx, GBP, IRG proteins. All 
known IFN-inducible GTPase families share biochemical and probably also 
mechanistical characteristics with the dynamins.  
 
1.2.1 Mx 
Rodent Mx1 and 2 homologs in human are MxA and B, the homologs of which are 
present in all vertebrates (Staeheli and Haller, 1985). Mx is exclusively induced by 
type I IFNs (Goetschy et al., 1989; Simon et al., 1991). Mx proteins share 
unambiguous homology to dynamin and share many biochemical properties with 
dynamins as well, including µM guanine nucleotides binding affinity, capacity of 
oligomerization and independency of extra GAP for GTP hydrolysis (Kochs et al., 
2002; Melen and Julkunen, 1997; Melen et al., 1992; Nakayama et al., 1993; 
Schwemmle et al., 1995). In IFN-stimulated cells human MxA and mouse Mx2 
localize in the cytoplasm, whereas mouse Mx1 localizes to the nucleus due to a 
nuclear localization signal at the C-terminus (Meier et al., 1988; Melen et al., 1992; 
Staeheli and Haller, 1985). Mx1 and human MxA have strong antiviral effects 
(Arnheiter and Meier, 1990; Hefti et al., 1999; Miura et al., 2001). MxA probably 
binds directly to viral nucleoproteins or capsid proteins, interfering with viral 
trafficking and assembly (Kochs et al., 2002; Kochs and Haller, 1999). The mode of 
action for the nuclear Mx1 is less known, probably involving the inhibition of primary 
transcription of virus RNA (Pavlovic et al., 1992). However, several Mx isoforms, 
such as human MxB, appear devoid of antiviral activity (Meier et al., 1990; Pavlovic 
et al., 1990). Nevertheless, a recent report suggested that MxB might have a function 
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in regulating nucleocytoplasmic transport and/or cell-cycle progression (King et al., 
2004).  
 
1.2.2 The guanylate-binding proteins 
The guanylate-binding proteins (GBPs) were among the first IFN-inducible proteins 
identified because of their spectacular induction by IFNs esp. IFN-γ (Boehm et al., 
1998; Cheng et al., 1985; Cheng et al., 1983). Seven GBP genes have been described, 
namely, hGBP1-7 in human (Cheng et al., 1991; Olszewski et al., 2006) and 
mGBP1-7 in mouse (Boehm et al., 1998; Olszewski et al., 2006; Wynn et al., 1991), 
respectively.Recently, the number of mGBP genes seem to expand to 11 (Klaus 
Pfeffer, personal communication). Similar to dynamin proteins, GBPs bind 
nucleotides with low affinity, hydrolyze GTP cooperately and form multimers 
(Praefcke et al., 2004; Praefcke and McMahon, 2004; Prakash et al., 2000; Prakash et 
al., 2000). The structures of hGBP1 in different nucleotide binding forms were solved, 
which suggested plausible G-domain dimmers (Ghosh et al., 2006; Prakash et al., 
2000; Prakash et al., 2000).  
Despite detailed knowledge of their structure and biochemistry, the function of the 
GBPs is still not clear. The antiviral effects of GBPs are weak (Anderson et al., 1999; 
Carter et al., 2005). Recently, however, GBPs have been proposed to exert complete 
different functions such as regulation of vasculogenesis (Gorbacheva et al., 2002; 
Guenzi et al., 2001; Guenzi et al., 2003).  
 
1.2.3. The IRG GTPases 
IFNs mediate antiviral effects to a broad spectrum of pathogens including viruses and 
various intracellular microbes. So far IFN-inducible GTPases mentioned above are 
mostly implicated in viral resistance. The last IFN-inducible GTPases described 
below however participate in cell-autonomous resistance against intracellular 
microbes. 
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1.2.3.1 Irg genes 
There are 25 Irg coding units in the C57BL/6 mouse, with 2 pseudo-genes and 21 
intact genes, locating on chromosome 7 (Irgc), 11 (Irga family), 18 (the rest of Irg 
genes) (Bekpen et al., 2005) (Fig.2). Only two Irg genes, IRGC and IRGM, are 
present in humans. Irg gene homologs are also found in other vertebrates such as dogs, 
zebrafish (Bekpen et al., 2005). In mouse, the open reading frame of Irg genes is 
typically encoded on a single long 3’ exon behind one or more 5’-untranslated exons. 
Perfect interferon-inducible motifs, ISRE and GAS, but no other recurrent promoter 
motifs such as NFκB-binding sites can be found for most of the chromosome 11 and 
18 Irg genes. Irgc on chromosome 7 is an exception (Bekpen et al., 2005).   
 
Figure 2. Phylogenetic relationship of mouse Irg GTPases. Unrooted tree (p-distance based on 
neighbour-joining method) of nucleotide sequences of the G-domains of the 23 mouse Irg 
GTPases, including the two presumed pseudo-genes Irga5 and Irgb7. The sources of all Irg 
sequences are given in Additional data file 1, and the nucleotide and amino acid sequences 
themselves are collected in the p47 (IRG) GTPase database from our laboratory website 
[http://db.aghoward.uni-koeln.de/public/database2/global/]. (Bekpen et al., 2005; Samadani et al., 
1996) 
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1.2.3.2 The expression of IRGs 
The cDNA of IRG-47 (Irgd), the first Irg gene discovered, was found in murine 
IFN-γ-induced pre-B cell lines (Gilly and Wall, 1992). Another 5 members of IRG 
family, TGTP (Irgb6), LRG-47 (Irgm1), IGTP (Irgm3), GTPI (Irgm2) and IIGP-1 
(Irga6) were subsequently discovered(Carlow et al., 1995; Carlow et al., 1998; Sorace 
et al., 1995; Taylor et al., 1996; Zerrahn et al., 2002). Based on phylogenetic 
principles, a naming scheme has been introduced using the core name IRG 
(immunity-related GTPases) (Bekpen et al., 2005). All IRGs including Irgd were 
found to be induced in different cultured cell types such as peritoneal, Raw 264.7 or 
bone marrow macrophages, fibroblast or endothelial cell lines, B or T cell lines under 
stimulated conditions. The inducers include IFN-γ, IFN-α/β, LPS or T cell receptor 
cross linking in the case of T cells, but not other cytokines such as IL-1, IL2, IL4, IL6, 
TNF-α (Carlow et al., 1998; Taylor et al., 1996; Zerrahn et al., 2002). Notably, IFN-γ 
was proved to be around 1,000 fold more efficient than IFN-α/β in the induction of 
tested members of IRG proteins (Carlow et al., 1998; Taylor et al., 1996). The 
importance of IFN pathway for the induction is evident. Mouse embryonic fibroblast 
from IFN-γR-/- but not IRF-1-/- mice was incapable of induction of IRG proteins with 
IFN-γ (Boehm et al., 1998). The induction by T cell receptor cross linking was 
obviously IFN-γR dependent (Zerrahn et al., 2002). LPS employed type I IFN 
pathway to induce IRG proteins, since in IFN-αR-/- cells the induction was blocked 
(Lapaque et al., 2006; Zerrahn et al., 2002). In STAT-1-/- murine bone marrow 
derived macrophages (BBM) the expression of IRG proteins after IFN-γ stimulation 
was completely abolished (MacMicking et al., 2003). Interestingly, direct infection of 
BMM or dendritic cells by Trypanosoma cruzi or Listeria monocytogenes stimulated 
expression of IRG proteins, which turned out to be triggered by type I IFN signaling 
in an autocrine manner (Koga et al., 2006). Two micro-array reports indicated that 
IRG proteins are expressed in hematopoietic stem cells, which is presumably due to 
bursts of developementally regulated IFN synthesis (Terskikh et al., 2001; Venezia et 
al., 2004).   
IRG proteins are expressed at very high levels in most tissue following infection with 
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pathogens. All 6 well known IRG proteins were strongly induced in liver infected by 
Listeria monocytogenes in an IFN-γR-/- dependent manner (Boehm et al., 1998). The 
infection with Listeria monocytogenes, Toxoplasma gondii and murine 
cytomegalovirus massively induced the expression of IRG proteins in spleen and liver 
(Collazo et al., 2001; Gavrilescu et al., 2004; Taylor et al., 2000), and a similar 
induction was observed in lung infected by Mycobacterium tuberculosis 
(MacMicking et al., 2003). The induction in spleen infected by Toxoplasma gondii 
was clearly abrogated in STAT-1-/- mice.  
Constitutive expression of Irgd and Irgm3 in thymus and spleen in the absence of 
infection was reported (Collazo et al., 2001; Taylor et al., 1996), which like the 
expression of Irg genes in hematopoietic stem cell could be responses to bursts of IFN 
expression at early developmental stages of myeloid differentiation. 
 
1.2.3.3 Biochemical properties, structure and interaction of IRG proteins 
IRG proteins are typically 47-kDa molecular weight, with a canonical G domain. 
Three of the mouse IRG proteins have the noncanonical sequence GX4GMS in place 
of the otherwise conserved form, GX4GKS, in the G1 nucleotide-binding motif. These 
two subfamilies have been designated GMS and GKS, respectively (Boehm et al., 
1998). The systematic biochemical and structural data are only available for one IRG 
protein, Irga6, a member from GKS group. (Ghosh et al., 2004; Uthaiah et al., 2003). 
Irga6 has low nucleotide binding affinity (µM range), hydrolyzes GTP to GDP 
cooperatively and oligomerizes in the presence of GTP, which recall the biochemical 
properties of dynamins (Ghosh et al., 2004; Uthaiah et al., 2003).Under physiological 
conditions, Irga6 should be predominantly GDP bound.  
A crystal structure of Irga6 was obtained recently, which is not similar to that of 
hGBP1. The apoprotein and GDP-bound forms both crystallized as symmetrical 
dimers, having a Ras-like G domain (Fig. 3A). Several lines of evidence suggest that 
the crystal dimmer interface is not a definitive interface of the GTP-bound oligomer, 
and most probably a drastically different dimer interface is adapted by dramatic 
conformational change when the protein oligomers start to form (Ghosh et al., 2004); 
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Pawlowski unpublished results). A second interface, involving a G domain: G domain 
dimer, has been suggested by site-directed mutagenesis, though no crystal structure of 
this hypothetic dimmer is yet available (Pawlowski and Wolf unpublished results). 
The putative second interface together with the dimer interface may allow for the 
construction of an oligomer with alternating use of these two interfaces (Fig. 3B).  
 
 
Irga6 like dynamins and GBPs can form oligomers which accelerate their hydrolysis 
of GTP. In vitro experiments demonstrated that one subunit of Irga6 protein can 
provide in trans a catalytic function to its interacting neighbour-subunit (Pawlowski 
unpublished results). In vitro Irga6 self-self interaction was detected, which was 
Figure 3. Structure and model of oligomerization for Irga6. (A) Crystal structure of Irga6 in the 
GDP-bound form (reprinted Ghosh et al. 2004, with permission from Elsevier, copyright 2004). 
The unit cell of the Irga6 crystal contained a rotationally symmetrical dimer with interactions 
between monomers in both the N-terminal domain and nucleotide-binding domain. A linker helix 
connects the helical C-terminal domain to the nucleotide-binding domain. A myristoylation motif 
at the extreme N terminus is not resolved in the structure. (B) Model for the oligomeric structure of 
Irga6 based on the dimer shown in A and an unpublished second interface in the G domain. The 
dimer interface in A is shown as a red line. HN, helical N-terminal domain; HC, helical C-terminal 
domain; G, nucleotide-binding domain. (Martens and Howard, 2006) 
A
B
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totally dependent on GTP binding (Papic and Hunn unpublished results). Furthermore, 
hetero-oligomeric interaction between IRG proteins esp. between GMS and GKS 
proteins in a nucleotide binding dependent manner were discovered (Hunn 
unpublished results). Since Irgm3 is mainly GTP bound under physiological 
conditions (Taylor et al., 1996; Taylor et al., 1997), in the IFN-γ induced cells 
GTP-bound GMS proteins could have a plausible role in maintenance of the inactive 
GDP-bound GMS proteins until the arrival of an infectious stimulus that requires their 
activation. The only published interaction partner for Irga6 is Hook-3 which is a 
microtubule motor-binding protein (Kaiser et al., 2004) and the significance of this 
interaction deserves more research.  
 
1.2.3.4 Subcellular localization of IRG proteins 
After stimulation with IFN, induced IRG proteins are distributed between different 
specific membrane compartments and the cytosol (Martens et al., 2004). All IRG 
proteins except for Irgd are membrane associated in their resting location. Irga6 is 
probably continuously exchanged between the cytosol and the ER membrane and the 
binding to the latter is due to an N-terminal myristoylation site. IRGM proteins are 
predominantly targeted to the Golgi membrane by a short sequence corresponding to 
helix K (αK) in the Irga6 crystal structure (Fig. 3A) (Ghosh et al., 2004). 
In inducible stable-transfected cell clones, where no IFN stimulation was present, 
Irga6 and Irgb6 fail to localize to their correct compartments e.g. the ER, which is not 
the case for GTP-binding deficient mutants (Martens et al., 2004). This 
mislocalization can be rescued by additional induction with IFN-γ or cotransfection 
with IRGM proteins, and in the latter case, IRGM GTP-binding deficient mutants are 
inactive (Hunn unpublished results).  
All IRG proteins tested so far are rapidly relocalized from their resting compartment 
to vacuolar compartment during infection. In Toxoplasma gondii infection, IRG 
proteins reposition to T. gondii parasitophorous vacuole (Martens et al., 2005), except 
for Irgm1, which however relocate to the mycobacterial phagosome (MacMicking et 
al., 2003) or latex bead containing phagosomes (Martens et al., 2004). Irgm3 has also 
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been detected on latex bead phagosomes but not on phagosomes containing 
heat-killed T. gondii (Butcher et al., 2005).  
 
1.2.3.5 Resistance of IRG proteins to intracellular pathogens 
Similar to Mx, IRG proteins are strongly implicated in IFN induced resistance 
however in distinct aspects. Mice deficient in IRG proteins have dramatic 
susceptibility phenotypes to many infectious intracellular bacteria and protozoa 
correlating well with loss of IFN-γ dependent resistance in mice (Collazo et al., 2001; 
MacMicking, 2004; MacMicking, 2005; Taylor et al., 2000) (Table 1). A few reports 
of viral infection in IRG-deficient mice revealed no susceptible phenotype (Taylor et 
al., 2000), and in transfected system Irgb6 and Irgm3 showed only weak, possibly 
insignificant effects to VSV and Coxsackie virus (Carlow et al., 1998; Zhang et al., 
2003).  
 
 
Table 1. Susceptibilities of IRG-deficient mice and cells to intracellular pathogens. This table 
summarizes various studies on IRGm1 (Collazo et al., 2001; Feng et al., 2004; MacMicking et al., 
2003; Santiago et al., 2005; Taylor et al., 2004), IRGm3 [(de Souza et al., 2003) (Feng et al., 2004; 
MacMicking et al., 2003; Taylor et al., 2000; Taylor et al., 2004) Z.Bernstein-Hanley, J. Coers, W. 
Dietrich, personal communication (Chlamydia, in vitro)], and IRGd (Collazo et al., 2001; 
MacMicking et al., 2003). Data for Irga6 (Toxoplasma gondii) are from Martens et al. (2005) and 
Parvanova and Reichmann (unpublished results); data for Irga6 (Leishmania and Listeria) are from 
Parvanova, E. von Stebut, O. Utermöhlen (unpublished results); data for Irga6 (Chlamydia) are 
from (Nelson et al., 2005) (in vitro, RNAi) and Z. Bernstein-Hanley & I. Parvanova (unpublished 
results) (in vivo). Data for Irgb10 (Chlamydia) are from Z. Bernstein-Hanley, J. Coers,W. Dietrich 
(personal communication) (in vitro, RNAi). bR, resistant; S, sensitive; Sm, knockout mouse 
sensitive; Rm, knockout mouse resistant; Sc, knockout cells sensitive; Sc., RNAi wild-type cells 
sensitive; Rc, knockout cells resistant. Where not speci.ed, the results are from knockout mice. ND, 
not determined. (Banchereau and Steinman, 1998; Martens and Howard, 2006) 
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The reasons why IRG-deficient mice died in these fatal diseases are not completely 
clear, possibly due to cytokine over-expression induced by an over-burden of 
pathogens arising from the failure of cell-autonomous resistance mediate by IRG 
GTPases (Feng et al., 2004; Santiago et al., 2005; Taylor et al., 2000). Another 
argument for the susceptibility is based on a pathological defect in the Irgm1 knock 
out mice which developed lymphpenia and bone marrow failure after infection with 
Mycobacteria and Trypanosoma (Feng et al., 2004; Santiago et al., 2005). The 
regulatory role of IRG proteins affecting lymphmyeoid differentiation needs to be 
further clarified, whereas the role of IRG proteins in cell-autonomous resistance 
against intracellular pathogens is increasingly supported.  
 
1.2.3.6 Cell-autonomous resistance mediated by IRG Proteins 
There is growing evidence favoring that the role of IRG proteins in resistance to 
intracellular pathogens is a cell-autonomous manner. Macrophages lacking Irgm1 and 
Irgm3 displayed greatly attenuated IFN-γ-induced inhibition of T.gondii growth 
(Butcher et al., 2005; Halonen et al., 2001). IFN-γ controls T. gondii infection 
significantly less efficiently in Irga6-deficient astrocytes (Martens et al., 2005). Under 
IFN-γ stimulation conditions five of known IRG proteins were concentrated very fast 
at the parasitophorous vacuoles in a GTP-binding dependent manner in T.gondii 
infected primary astrocytes (Martens et al., 2005) or various of other cell types (Hunn 
and Könen-Waisman unpublished results). Remarkable vesiculation of 
parasitophorous vacuolar membranes that were positive for IRG proteins were 
observed and parasitophorous vacuolar membrane lost its integrity and subsequently T. 
gondii inside the disrupted vacuole undergoes deterioration (Martens et al., 2005). 
Over-expression of wild-type Irga6 accelerated the vacuolar disruption and the 
nucleotide binding mutant Irga6 (K82A) acting as dominant negative form prevented 
relocalization and the cells do not control the infection normally (Martens et al., 
2005). Although no concentration of Irgm1 was found at parasitophorous vacuoles 
(Butcher et al., 2005; Martens et al., 2005), it may exert its function distantly. As 
mentioned above, GMS interact with GKS proteins and in IFN-γ induced cells 
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GTP-bound GMS is essential for correct subcellular localization of GDP-bound form 
of GKS. Since GDP-bound form of GTPases normally represents an inactive state of 
the protein, it is plausible to argue that GMS proteins interact with GKS proteins and 
act as negative regulators at cellular membrane. When T. gondii enter the cell, 
parasitophorous vacuole (PV) membrane is derived from plasma membrane which is 
free of GMS proteins. Hence on the PV membrane that is devoid of GKS inhibitors, 
GKS proteins may become activated and start to oligomerize. The situation however 
becomes complicated in view of the observation that, soon after T.gondii invasion (5 
min), one member of GMS protein, Irgm2, starts to accumulate at the PV membrane 
(Yang Zhao personal communications).  
It seems that the above model is not the only modality which IRGM proteins adopt in 
pathogen resistance. As mentioned Irgm1 is associated with the mycobacterial 
phagosome in IFN-treated macrophages, which correlates with delayed and limited 
phagosome acidification (MacMicking et al., 2003).  
Even though mechanisms of the resistance mediated by Irgm1 against Listeria 
monocytogenes (Collazo et al., 2001) and T.cruzi (Santiago et al., 2005) is not well 
understood, it cannot be explained by the same effector model as that for T .gondii, 
because these two pathogens escape rapidly from the vacuole to the cytosol after their 
entry into the cell. Several recent reports implicate Irgm1 in IFN-γ induction of 
autophagy, which in turn has been suggested as a resistance mechanism against 
several intracellular pathogens including Listeria monocytogenes (Rich et al., 2003) 
and M. tuberculosis (Gutierrez et al., 2004).  
The cell-autonomous resistance conferred by IRG proteins against several other 
intracellular pathogens such as Legionella and Chlamydia trachomatis was also 
reported with unexplained mechanisms (Martens and Howard, 2006; Nelson et al., 
2005).  
 
1.3. NKT cell 
NKT cells are narrowly defined as a T cell lineage expressing NK lineage receptors, 
in addition to semi-invariant CD1d-restricted αβ TCRs. More than 80% of these TCRs 
 Introduction               
 15
are Vα14-Jα18/Vβ8, Vβ7, and Vβ2 in mouse (or Vα24-Jα18/Vβ11 in human), and the 
remaining are Vα3.2-Jα9/Vβ8, Vα8/Vβ8, and other TCRs (Cardell et al., 1995; Park 
et al., 2001). Both the Vα14 and the non-Vα14 NKT cells exhibit autoreactivity to 
CD1d-expressing cells in vitro (Bendelac et al., 2007).  
 
1.3.1 NKT cell distribution 
Vα14 NKT cells represent 0.5% of the T cell population in the blood and peripheral 
lymph nodes, 2.5% of T cells in the spleen, mesenteric, and pancreatic lymph nodes, 
and up to 30% of T cells in the liver (Matsuda et al., 2000). Vα14 NKT cells reside 
within the liver sinusoids and their expression of CXCR6 matches the expression of 
CXCL16 on the endothelial cells lining the sinusoids and appears to be important for 
survival rather than for migration (Geissmann et al., 2005). In humans, Vα24 NKT 
cells appear to be 10 times less frequent in all these locations. NKT cell frequency 
appears to be a stable phenotype under the genetic control of at least two recessive 
loci in mouse (Esteban et al., 2003; Rocha-Campos et al., 2006). Low Vα14 NKT cell 
expressors in mice include NOD and SJL (Baxter et al., 1997; Gombert et al., 1996; 
Yoshimoto et al., 1995). Vα14 NKT cells are present in rats (Matsuura et al., 2000; 
Pyz et al., 2006), and, based on genomic and functional studies of CD1d, they may be 
absent in cows (Van Rhijn et al., 2006). 
 
1.3.2 NKT cell ligands 
mVα14 and hVα24 NKT cells, irrespective of their Vβ-Dβ-Jβ chain usage, recognize 
α-galactosylceramide (αGalCer) extracted from a marine sponge that prolonged 
survival of mice bearing B16 melanoma (Brossay et al., 1998; Kawano et al., 1997; 
Kobayashi et al., 1995). Closely related structures were found as NKT cell ligands 
that act as substitutes for LPS in the cell wall of Sphingomonas, a Gram-negative, 
LPS-negative member of the class of α-proteobacteria (Kawahara et al., 2000; 
Kawasaki et al., 1994). These glycosphingolipids have only one sugar, galacturonyl or 
glucuronyl, α-anomerically branched to the ceramide backbone. Recently the self 
antigen of NKT cells in mouse and human, isoglobotrihexosylceramide (iGb3). 
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(Bendelac et al., 1995; Exley et al., 1997; Park et al., 1998). This autoreactivity of 
endogenous ligand with CD1d is important for NKT cell activation in certain bacteria 
in infection and NKT cell thymic development (Bendelac, 1995; Brigl et al., 2003; 
Mattner et al., 2005; Park et al., 2000; Zhou et al., 2004). In contrast, the self and 
foreign antigens recognized by non-Vα14 NKT cells remain to be identified.  
 
1.3.3 Lipid presentation in NKT cell 
CD1d is prominently and constitutively expressed by APCs such as DCs, 
macrophages, and B cells (Brossay et al., 1997; Roark et al., 1998), with relatively 
modest changes stimulated by TLR activation and inflammatory cytokines (Skold et 
al., 2005). CD1d is also expressed on cortical thymocytes, to which the autoreactivity 
is essential for NKT cell development (Bendelac, 1995), and on Kupffer cells and 
endothelial cells lining liver sinusoids (Geissmann et al., 2005). Hepatocytes express 
CD1d constitutively in mouse and upon disease induction in human, for example, in 
the context of hepatitis C (de Lalla et al., 2004). 
Newly biosynthesized CD1d molecules, likely containing lipid chains, reach the 
plasma membrane and are internalized through an AP-2/AP-3 clathrin-dependent 
pathway to late endosomal/lysosomal compartments (Jayawardena-Wolf et al., 2001; 
Kang and Cresswell, 2002; Kang and Cresswell, 2002; Roberts et al., 2002), where 
lipid exchange is performed by saposins (Kang and Cresswell, 2004; Zhou et al., 
2004). CD1d extensively recycles between lysosome and plasma membrane, allowing 
further lipid exchange. Endosomal/lysosomal trafficking of CD1d is essential for lipid 
presentation to mVα14 NKT cell, since mice deficient in biogenesis of lipid exchange 
proteins like saposins, microsomal triglyceride transfer protein (MTP) or NPC1, lack 
NKT cells and exhibited greatly impaired ability to present various endogenous and 
exogenous NKT ligands (Brozovic et al., 2004; Honey et al., 2002; Kang and 
Cresswell, 2004; Sagiv et al., 2006; Zhou et al., 2004). Notably, however, the 
non-Vα14 NKT cell ligands, which are still not identified, are normally presented by a 
tail-truncated CD1d, which is defective in endosomal trafficking and likely presents 
antigens loaded in the secretory pathway or at the cell surface (Chiu et al., 1999). 
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1.3.4 NKT cell development 
NKT cell precursors diverge from mainstream thymocyte development at the 
CD4+CD8+ double-positive (DP) stage (Bendelac et al., 1996; Gapin et al., 2001). 
Upon expression of their canonical TCRα chain, NKT cell precursors are positively 
selected by interacting with endogenous ligands, presented by CD1d expressed on 
other DP thymocytes in the cortex (Benlagha et al., 2005; Gapin et al., 2001). 
Down-regulation of CD8 leads to appearance of CD4+ and then further 
Down-regulation of CD4 in a subgroup of NKT cell precursors produce 
double-negative (DN) cells (Borowski and Bendelac, 2005; Cannons et al., 2004; 
Pellicci et al., 2002; Sivakumar et al., 2003). NKT cell precursors then undergo 
several rounds of cell division characterized by production of IL4 and IFN-γ and 
acquire a memory/effector phenotype prior to thymic emigration (Pellicci et al., 2002; 
Stetson et al., 2003). Acquisition of NK lineage receptors, including NK1.1, occurs 
after emigration to peripheral tissues, except for a minor subset of thymic NKT cell 
residents (Benlagha et al., 2002; McNab et al., 2005; Pellicci et al., 2002). 
 
1.3.5. NKT cell function 
NKT cells have been implicated in a broad array of disease conditions ranging from 
infections, various forms of autoimmunity, atherosclerosis, allergy, and tumor. 
 
1.3.5.1 NKT cell activation by αGalCer 
A cascade of activation events following the exogenous administration of NKT 
ligands such as αGalCer has been characterized (Fig. 4). The central feature is a 
reciprocal activation of NKT cells and DCs. Resting DCs presents αGalCer to NKT 
cells, inducing NKT cells to upregulate CD40L and Th1 and Th2 cytokines and 
chemokines; CD40 cross-linking induces DCs to upregulate CD40, B7.1 and B7.2, 
and IL-12, which in turn enhances NKT cell activation and cytokine production 
(Kitamura et al., 1999; Tomura et al., 1999). Propagation of this reaction involves the 
activation of NK cell cytolysis and IFN-γ production (Carnaud et al., 1999; Eberl and 
MacDonald, 2000) and, most importantly, the upregulation of DC costimulatory 
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properties and MHC class I– and MHC class II–mediated antigen presentation to 
prime robust adaptive immune responses (Fujii et al., 2004; Fujii et al., 2003; 
Gonzalez-Aseguinolaza et al., 2002). Importantly, TLR signalling is not involved in 
these responses.  
 
 
1.3.5.2 NKT cell activation by bacterial infection 
Glycosphingolipids closely related to αGalCer were reported in the cell wall of 
Sphingomonas (Kawahara et al., 2000; Kawasaki et al., 1994), a prominent 
Gram-negative, LPS-negative member of α-proteobacteria. During infection, 
Sphingomonas is phagocytosed by macrophages and DCs and elicits an activation 
cascade similar to exogenous αGalCer. NKT cell activation enhances microbial 
Figure 4. Cellular and molecular network activated by the NKT ligand αGalCer. DCs and 
perhaps also Kupffer cells (macrophages) lining the liver sinusoids (where NKT cells accumulate) 
are at the center of a cellular network of cross-activation, starting with NKT cell upregulation of 
CD40L, secretion of Th1 and Th2 cytokines and chemokines, and DC superactivation to prime 
adaptive CD4 and CD8 T cell responses. NKT cells can provide help directly to B cells for 
antibody production and can also rapidly activate NK cells. CXCR6/CXCL16 interactions provide 
essential survival signals for NKT cells. EC, endothelial cell. (modified from Bendelac et al., 2007; 
Costa et al., 1988) 
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clearance by 15- to 1000-fold within the first 2–3 days of infection (Kinjo et al., 2005; 
Mattner et al., 2005). TLR-mediated signaling exerts a much weaker direct effect 
relative to that of NKT cells.  
Interestingly, many other bacteria, particularly the Gram-negative, LPS-positive ones, 
which though not having NKT cell ligands, can activate NKT cells, however, by 
triggering autoreactive NKT cell responses (Brigl et al., 2003; Mattner et al., 2005). 
In the case of Salmonella, blocking of biogenesis of iGb3 or blocking iGb3 itself in 
DC abrogated the activation of NKT cells (Mattner et al., 2005). NKT cell activation 
by Gram-negative, LPS-positive Salmonella is also absolutely dependent upon TLR 
signaling, suggesting a possible relationship between TLR and endogenous NKT cell 
ligand presentation.  
 
1.3.5.3 NKT cell and parasitic and viral infection and noninfectious diseases 
Only preliminary experimental data are available for NKT cell activation in parasitic 
and viral infection. Malaria circumsporozoite and Schistosoma mansoni eggs were 
reported to activate NKT cells (Mallevaey et al., 2006; Molano et al., 2000; Romero 
et al., 2001). Modest defects in the clearance of some viruses have been reported in 
CD1d-deficient mice (Ilyinskii et al., 2006) or coxsackie B3 (Huber et al., 2003).  
There are many reports suggesting a role of NKT cells in a wide variety of 
noninfectious disease conditions. A detailed mechanistic understanding however is 
still lacking. The relative deficiency of NKT cells in NOD mice (Baxter et al., 1997; 
Gombert et al., 1996), suggested a causal relationship with diabetes. Hyperreactive 
NKT cells accumulated in aging NZB/W mice (Forestier et al., 2005) implying a role 
of NKT cells in lupus. CD1d- and Jα18- deficient mice exhibited decreased 
hyperreactivity in asthma (Lisbonne et al., 2003). CD1d deficiency also decreased the 
level of stherosclerosis in LDL receptor deficient mice (Thomas et al., 2006).  
 
1.4 Aim of work 
It had long been accepted in the field that IRG proteins were expressed only upon 
stimulation of IFNs in vitro, and in vivo the expression was also exclusively induced 
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by IFNs secreted accompanying pathogen infection or inflammation events, with only 
a few exceptions like constitutive expression in lymphoid organ, which was 
presumably also due to developmental bursts of regulatory IFN-γ expression. 
However all the observations above esp. those for in vivo expression were based on 
only a few reports that were neither systematic nor quantitative. Several basic 
questions were still open such as whether there was really constitutive expression for 
IRG proteins? If yes, how were the expression patterns and what were the causes of 
the expression in vivo? Finally what was the biological relevance of constitutively 
expressing IRG proteins? These were the questions we tried to answer in the current 
thesis. A combination of biochemical, cell biological, molecular biological and 
genetic approaches was applied to gain a detailed understanding of the expression of 
IRG proteins in vivo. Firstly, we would examine whether IRG proteins were 
constitutively expressed in uninfected laboratory mice tissues, with biochemical 
methods. Secondly, if basal expression is found, we would investigate the relationship 
of this expression with the IFN pathway. Thirdly, we would explore in which cell in 
vivo IRG proteins are constitutively expressed and what the relevance of this 
expression might be to the resistance of intracellular pathogens, using cell biological 
methods. Fourthly, we would try to understand the causes of particular focal 
expression patterns of Irga6 in liver and kidney, which maybe due to IFN production, 
using biochemical, and molecular biological and genetic methods. Fifthly if IFNs 
indeed induced the focal expression of Irga6, we would like to know if a certain 
subset of T cells like NKT cells should be responsible for the local production of 
IFN-γ using molecular biological methods. Finally we would like to understand what 
might be the reasons of local NKT cell activation by biochemical methods.
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2. Materials and Methods 
 
2.1 Materials 
2.1.1 Chemicals, Enzymes and Kits 
All chemicals used were graded p.A. and purchased from Aldrich (Steinheim), 
Applichem (Darmstadt), Baker (Deventer, Netherlands), Boehringer Mannheim 
(Mannheim), GE Healthcare (München), GERBU (Gaiberg), Gibco BRL (Eggelstein), 
Merck (Darmstadt), Riedel de Haen (Seelze), Roth (Karlsruhe), Serva (Heidelberg), 
Sigma-Aldrich (Deisenhofen), ICN biochemicals, Oxoid (Hampshire, UK). Buffers 
and solutions were prepared with deionised and sterile water or Ultra pure water 
derived from Milli-Q-Synthesis (Millipore, Schwalbach). All solutions used for 
techniques designed to isolate, process or detect RNA were treated with DEPC. 
All restriction enzymes were purchased from New England Biolabs (Frankfurt/Main); 
T4 DNA ligase (New England Biolabs); RNase A (Sigma); shrimp alkaline 
phosphatase (SAP) (USB, Staufen; Amersham, Freiburg); Proteinase K (Merck); 
Thermus aquaticus (Taq) polymerase was prepared by Rita Lange; SP6 RNA 
polymerase and T7 RNA polymerase (Roche, Mannheim) 
Plasmid Midi kit, RNeasy Mini kit, RNeasy Micro kit (QIAGEN, Hilden), 
Terminator-cycle Sequencing kit version 3.1 (ABI, Foster City, CA, USA), Rapid 
PCR product purification kit (Roche), SuperScript First-Strand Synthesis System for 
RT-PCR (Invitrogen, Karlsruhe), pGEM-T easy Vector System I (Promega, Madison, 
USA), Rediprime DNA labeling system (Amersham Life Sciences), HistoGreen 
(Linaris, Wertheim-Bettingen), alkaline phosphatase kit III (Vector laboratory, 
Linaris), LightCycler SYBR Green I PCR kit (Roche, Germany).  
 
2.1.2 Media 
Luria Bertani (LB) medium 
10g bacto tryptone, 5g yeast extract, 10g NaCl, 1 l dH2O, for plates additionally 15g 
agar was added 
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IMDM (Iscove’s Modified Dulbecco’s Medium) 
Supplemented with 10 % FCS, 2 mM Glutamine, 1 mM sodium pyruvate, 100 U/ml 
Penicillin, 100 µg/ml Streptomycin, 1x non-essential amino acids 
DMEM (Dulbecco’s Modified Eagle Medium) 
Supplemented with 10% FCS, 100 U/ml Penicillin, 100 µg/ml Streptomycin, 1x 
non-essential amino acids 
DMEM/Ham’s F12 1:1 Medium 
Supplemented with 10% FCS, 1% ITS+, 0.1 µM dexamethasone and 100 U/ml 
Penicillin/100 µg/ml streptomysin buffered by 15mM HEPES 
 
2.1.3 Serological reagents 
Serological reagents used were: Anti-Irga6 165 rabbit antiserum (home made in Prof. 
Howard’s lab, Institute for Genetics, Köln), anti-Irga6 mouse monoclonal antibody 
(mAb) 10D7 (Dr. Zerrahn, Berlin), anti-Irgm3 I68120 mAb (BD Transduction 
Laboratories, Lexington, Kentucky, United States), anti-Irgb6 A20 goat antiserum 
(Santa Cruz Biotechnology, Santa Cruz, California, United States), anti-Irgm1 A19 
goat antiserum (Santa Cruz) for immunofluorescence and L115 B0 rabbit antiserum 
raised against the peptides QTGSSRLPEVSRSTE & NESLKNSLGV-RDDD, 
anti-Irgd 2078 rabbit antiserum raised against the peptides CKTPYQHPKYPKVIF & 
CDAKHLLRKIETVNVA, anti-GRA7 5–241–178 mouse mAb (gift from R. Ziemann, 
Abbott Laboratories, Abbot Park, Illinois, United States), anti-Gm130 mAB (BD 
Transduction Laboratory), anti-calnexin rabbit antiserum (Biomol, Hamburg), rat 
anti-CD3-12 mAb (Vector Laboratories, Linaris), rat anti-F4/80 mAb (Serotech), 
anti-TCR Vβ8 mAb (BD Pharmingen), goat anti-mouse Alexa 546/488, goat 
anti-rabbit Alexa 546/488, donkey anti-goat Alexa 546/488, donkey anti-mouse Alexa 
488, donkey anti-rabbit Alexa 488, (Molecular Probes, Eugene, Oregon, United 
States), donkey anti-rabbit HRP (Amersham), Goat anti-rat AP (SIGMA).  
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2.1.4 Mice 
C57BL/6 and CB20 mice were obtained from the mouse facility in Institute for 
Genetics Uni. Köln, where all mice were maintained in specific pathogen-free 
conditions. Irga6-/- mice were kindly provided by Dr. Iana Parvanova (Uni. Köln, 
Köln). IFN receptor deficient mice (IFNAR, IFNGR, IFNAGR), TLR-2/4-/-, TLR-9-/- 
and MyD88-/- were kindly provide by Prof. Dr. Marina Freudenberg 
(Max-Planck-Institut für Immunbiologie, Freiberg). IFN-γ-/- mice were kindly 
provided by Dr. Oberdan LEO (Université Libre de Bruxelles, BELGIUM). STAT-1-/- 
mice were kindly provided by Dr. Thomas Kolbe (University of Veterinary Medicine, 
Vienna). RAG-1-/- mice were kindly provided by Dr. Heike Weighardt (Technische 
Universitaet Muenchen, Munich). JHT mice were kindly provided by Prof. Dr. Ari 
Waisman (Johannes Gutenberg-Universität Mainz, Mainz). Gp130-/- mice were kindly 
provided by Prof. Dr. Jens Brüning (Uni. Köln, Köln). Germ-free mice were obtained 
from three sources namely, kindly provided by Mr. Rudolf Jörg (University of Zürich, 
Zürich) and Dr. Jocelyne Demengeot( Instituto Gulbenkian de Ciência, Portugal), or 
purchased from the Karolin's Institute in Stockholm.  
Mice were infected i.p. with L.monocytogenes strain EGD at LD1/2.  
 
2.2 Molecular biology 
2.2.1 PCR, ligation and agarose gel electrophoresis 
PCR (polymerase chain reaction) was used for the amplification of the templates for 
northern blot probes, the in situ hybridization probes and detection of gene-specific 
transcripts from cDNA. The standard reaction mix included template DNA that varies, 
10 pmol of each primer, 2.5 U Taq DNA polymerase, 200 pmol dNTP-mix, 2.5 µl 
50mM MgCl2, 5 µl 10x PCR buffer (200mM HEPES pH8.4, 500mM KCl), added up 
to total a volume of 50 µl with H2O. Primers were bought from Invitrogen and 
Operon (Köln). 
PCR products were purified using the Rapid PCR purification kit (Roche). Yield of 
DNA was estimated by agarose gel electrophoresis. Vector and insert were mixed at a 
ratio of 1:3 and ligated in a total volume of 10 µl with T4 DNA ligase overnight at 
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16°C. 
DNA was seperated by agarose gel electrophoresis in 1x TAE buffer (0.04 M Tris, 0.5 
mM EDTA, pH adjusted to 7.5 with acetic acid). Migration of the samples was 
visualized by using bromphenol blue and xylene-cyanol. The DNA was stained with 
ethidium bromide (0.3µg/ml), exposed to UV-light and documented with the 
BioDocAnalyze 2.1 equipment (Biometra, Göttingen). 
 
2.2.2 Competent cells and transformation 
2 ml LB medium supplemented with 20 mM MgSO4, 10 mM KCl were inoculated 
with one E. coli colony and cultured overnight at 37°C. The culture was then diluted 
1:100 and incubated at 37°C for approximately 2 h until a OD600 density of 0.45 was 
reached. The Culture was incubated 10 min on ice and the cells were then collected by 
centrifugation for 5 min at 6.000 rpm at 4°C. The cells were resuspended in TFB 1 
(30 mM KOAc, 50 mM MnCl2, 100 mM RbCl, 10 mM CaCl2, 15% (w/v) glycerine, 
pH 5.8; 30 ml for 100 ml culture) and incubated for 10 min on ice. After pelleted by 
centrifugation for 5 min at 6.000 rpm at 4°C, the cells were resuspended in TFB 2 (10 
mM MOPS, pH 7.5, 75 mM CaCl2, 100 mM RbCl2, 15 % w/v glycerine; 4 ml for 100 
ml culture). Aliquots of 100 µl of competent bacteria were frozen at -80°C. 
A 100 µl aliquot of competent bacteria was thawed on ice. 2µl of the ligation reaction 
or 5 ng of plasmid was added and mixed well before incubating for 20 min on ice. 
The cells were then heat-shocked for 45 sec at 42°C, followed by 5 min incubation on 
ice. 1 ml of LB medium was added and cells were incubated for 30-45 min on roller at 
37°C. 100-500 µl of this culture were plated on LB agar plates containing the 
appropriate antibiotics for selection. 
 
2.2.3 Plasmid DNA isolation from bacteria 
1.5 ml from 3 ml overnight LB cultures supplemented with the appropriate antibiotics 
was harvested by centrifugation for 5 min at 13,000 rpm. Cells were resuspended in 
100 µl P1 (50 mM Tris-Cl, pH 8.0,  10 mM EDTA,  100 µg/ml RNase A)  and 
lysed by the addition of 100 µl P2  (200 mM NaOH, 1 % SDS) for 5 min at RT. 
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Alkaline lysis was stopped by adding 130 µl P3  (3 M KAc, pH 5.5). Cellular debris 
and genomic DNA were pelleted by centrifugation for 20 min at 13,000 rpm. The 
supernatant was mixed with 700 µl 100% ethanol and plasmid DNA was pelleted by 
centrifugation for 15 min at 13,000 rpm. The pellet was then washed with 1 ml 70% 
ethanol and spun again for 5 min at 13,000 rpm. The supernatant was removed and 
the pellet was air dried before resuspending in 50 µl Tris pH 8.0.For larger yield the 
Plasmid Midi kit (QIAGEN) was used. 
 
2.2.4 DNA-Sequencing 
DNA was sequenced using the dideoxy-chain termination method (Sanger 1977). The 
ABI 3730 sequencer in the Cologne Centre for Genomics (CCG) was used with the 
ABIR Prism™ BigDye V3.1 Terminator Cycle Sequencing Reaction kit (PE Applied 
Biosystems).  
 
2.2.5 Total RNA isolation and cDNA synthesis 
Mice were sacrificed and organs were taken and stored in the RNA stabilizing 
solution RNAlater (QIAGEN). Total RNA was extracted from tissues using the 
RNAeasy Mini Kit (QIAGEN) as described in user’s manual. The integrity of total 
RNA was tested on agarose gels.  
The SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen, Karlsruhe) 
using oligo(dT) primers and random hexamers (1:1) was employed for generating 
cDNA from total RNA. 
 
2.2.6 Reverse-transcriptase PCR 
1µl cDNA from liver and T cells or 2-4 µl of cDNA from laser dissected materials 
(2.3.5) were used in each of the following RT-PCR reaction as templates. Primers 
located in different exons were used to generate a specific product only from cDNA 
but not from genomic DNA (Table 2). For nested-PCR, 1µl PCR product of first 
round of PCR was used as template for the second PCR, which made use a second 
internal 5’ or 3’ primer and the common 3’ or 5’ primer, and the cycle number was 
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always 45 for each round of PCR. All final PCR-products were verified by 
sequencing. 
Table 2. Primers used in reverse-transcriptase PCR. 
primer name primer sequence 5’ to 3’ product size
CTGAGACAATGAACGCTACACA IFNγ 
TTATTGGGACAATCTCTTCCC 
507bp 
ACTGGCAAAAGGATGGTGAC IFNγ nest 
TTATTGGGACAATCTCTTCCC 
332bp 
GGT(G/T)T(A/C/T)(C/T)TGGTA(C/T)(A/C/T)(
A/G)(A/C/G/T) CA 
TCR β chain 
TCAGGCAGTAGCTATAA 
450bp 
GGT(G/T)T(A/C/T)(C/T)TGGTA(C/T)(A/C/T)(
A/G)(A/C/G/T) CA 
TCR β chain nest 
GGTGGAGTCACATTTCT 
280bp 
CTAAGCACAGCACGCTGCACA TCR Vα14 chain 
GAAGCTTGTCTGGTTGCTCCAG 
350bp 
CTAAGCACAGCACGCTGCACA TCR Vα14 chain nest 
TCGGTGAACAGGCAGAGGGTG 
220bp 
TGCAGTTATGAGGACAGCACTT TCR Vα2 chain 
GAAGCTTGTCTGGTTGCTCCAG 
480bp 
TGCAGTTATGAGGACAGCACTT TCR Vα2 chain nest 
TCGGTGAACAGGCAGAGGGTG 
350bp 
ACGCCACTCTCCATAAGAGCA TCR Vα8 chain 
GAAGCTTGTCTGGTTGCTCCAG 
360bp 
ACGCCACTCTCCATAAGAGCA TCR Vα8 chain nest 
TCGGTGAACAGGCAGAGGGTG 
230bp 
TTCCATCGGACTCATCATCAC TCR Vα17 chain 
GAAGCTTGTCTGGTTGCTCCAG 
340bp 
TTCCATCGGACTCATCATCAC TCR Vα17 chain nest 
TCGGTGAACAGGCAGAGGGTG 
210bp 
GTCTACATGTTCCAGTATGACTCCACTCACGG mouse GAPDH 
GTTGCTGTAGCCGTATTCATTGTCATACCAGG 
837 bp 
 
2.2.7 Real-time PCR 
Real-time quantitative polymerase chain reaction analysis was performed using the 
cDNA generated as described in 2.2.5 or 2.3.5. PCR was carried out in a Light Cycler 
I System (Roche, Germany) using a LightCycler SYBR Green I PCR kit (Roche, 
Germany) following the manufacturer's instructions. The 5’ primers specific for Irga6 
1A (5’-TGCTTCCTGAAGCTGAACTA-3’) and 1B (5’-ACCGAGGGCTATTCCTC 
                                                  Materials and Methods 
 27
TCA-3’) together with a 3’ primer on the coding exon (5’-CAGAGAAGGGATGAT 
ATTCAC-3’) were used to detect expression level of Irga6 1A and 1B transcript forms 
as target genes. 5’ primer (5’-GTCTACATGTTCCAGTATGACTCCACTCACGG-3’) 
and 3’ primer (5’-GTTGCTGTAGCCGTATTCATTGTCATACCAGG-3’) specific for 
mouse GAPDH were used to detect mGAPDH as reference gene as input control. 
cDNA was synthesized from total RNA extract of liver or collected sections of Irga6 
focal and non-focal expression in liver with LMD technique as described in 2.3.5. 2-4 
µl of cDNA solution from materials collected by LMD was used as templates. PCR 
was programmed as recommended by the user’s manual. Primer efficiency for Irga6 1A, 
1B or mGAPDH was determined using liver cDNA dilution serial (1, 1/10, 1/100…) as 
templates and the method was described previouly (Pfaffl, 2001). The ratio of of 
“patch” to “non-patch” for Irga6 1A or 1B expression was then determined by PFAFFL 
METHOD (Pfaffl, 2001). Melting curve analyses were performed to verify the 
amplification specificity. Each sample was tested in duplicate or triplicate. To 
determine the ratio of Irga6 1A specific products in the final PCR products, final 
products of PCR for 1A were cloned in to pGEM-T-easy (Promega) vector and many 
clones were sequenced. The percentage of 1A clones was then calculated.  
 
2.2.8 T cell receptor repertoire screening  
In order to determine the T cell receptor Vβ usage and Vα14 junctional diversity, 
nested-RTPCR was first performed. cDNA from more than 50 Irga6 cored patches 
collected by LMD or cDNA of 1,000 lymphocytes from mesenteric and cervical 
lymph nodes were synthesized as described in 2.3.5. 1µl or 2-4µl cDNA from T cells 
or Irga6 patches were taken as template for the first round of PCR, the product of 
which was used as template for the next round of PCR. 45 cycles were used for both 
PCR reactions. The Vβ8 and Cβ primers (Kawagishi et al., 2003), Vα14 and Cα 
primers (Lantz and Bendelac, 1994), Vα2, Vα8, Vα17 primers (Yoshida et al., 2000b) 
were described before (Table 2). The final products of nested-PCR were cloned into 
pGEM-T-easy (Promega) and clones were sequenced. The sequences were then 
compared to classical TCR Vα sequences in the database online using 
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IMGT/V-QUEST (http://imgt.cines.fr/), and the clones with a sequence identity of 
more than 95% to known Vα sequences were identified as correct Vα clones. Clones 
were classified into groups with same junctions and representatives from each group 
were selected aligned and analyzed with free software GeneDoc (Version 2.6.002) 
(http://www.nrbsc.org) and Vector NTI (Version 9, Invitrogen).  
 
2.2.9 Northern blot analysis 
5 µg of total RNA was separated on 1% agarose/formaldehyde gels and transferred 
onto Hybond-N+ membrane (Amersham Biosciences, Uppsala, Sweden) by standard 
procedures. The blots were probed with randomly primed [α-32P]dCTP-labeled Irga6 
or murine -GAPDH ORF using the Rediprime DNA labeling system (Amersham Life 
Sciences). Hybridizations were performed overnight at 42°C in a buffer containing 
50% formamide, 5x Denhardt’s solution, 5x standard saline-phosphate-EDTA (SSPE), 
1% SDS, and 10% dextran sulfate. Membranes were washed under stringent 
conditions. The hybridization signal was detected by autoradiography, using Kodak 
X-OMAT AR films. Labeled ORF of mouse glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as a control probe to reveal the amount of loaded 
total RNA, and the RNA Millenium Marker (Ambion) was used as the RNA size 
standard. 
 
2.2.10 Western blot analysis 
Mice were sacrificed and organs were taken, snap frozen in liquid nitrogen and 
grinded. 10 µl RIPA buffer (150 mM NaCl, 50 mM Tris, 1% NP-40, 0.1% SDS, 0.5% 
deoxycholate, 5 mM EDTA, 1% Triton X-100, pH 8.0, one Complete Mini Protease 
Inhibitor tablet per 10 ml buffer (Roche) was added for each mg of tissues. The 
tissues were then homogenized with 20 gauge syringe. The homogenized lysate was 
incubated for 20 min on ice and then centrifuged for 30 min at 23,000 g. The 
supernatant was taken and analyzed by Western blot.  
Protein samples for instance tissue or cell lysates were separated by 10% SDS-PAGE 
and then transferred to a nitrocellulose membrane by electroblotting. After transfer the 
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membrane was stained with Ponceau S (0.1 % (w/v) Ponceau-S in 5 % (v/v) acetic 
acid) (SIGMA) to locate protein size standard Page RulerTM on the membrane. Then 
unspecific protein binding sites on the membranes were blocked by incubation for 1 h 
at RT in 5 % milk powder, 0.1 % Tween20 in PBS. Antisera/antibodies were diluted in 
10 % FCS, 0.1 % Tween20 in PBS. Protein bands were visualized using the enhanced 
chemiluminescence (ECL) substrate.   
 
2.3. Histology 
2.3.1 Tissue preparation and section 
Mice tissues were taken and fixed overnight in 4% paraformaldehyde in TBS at 4°C. 
Tissues were washed in PBS and 0.89% NaCl 1 hour each before dehydrated with an 
ethanol serial at 4°C (50%, 70%, 90%, 96% each step 4h) and then in isopropanol 8 h 
at RT. A paraffin:isopropanol (1:1) solution was applied to the tissues overnight before 
the evaporation of the isopropanol 8h at 60°C. Fresh paraffin was then exchanged 
several times (2h each) at 60°C before the tissues were incubated in fresh paraffin and 
moved to RT. The embedded tissues were cut with a microtome RM 2065 (Leica 
Microsystems, Wetzlar) into 6 µm thick serial sections, put on SuperFrost slides 
(Menzel, Braunschweig) and dried at 40°C overnight. Before staining, sections were 
dewaxed with Xylene (2x 10 min), then rehydrated by an ethanol series (100%, 95%, 
90%, 70%, 30%, PBS each step 3-5 min) and postfixed for 1 h in 4% 
paraformaldehyde in PBS. For frozen section, tissues were snap-frozen in liquid 
nitrogen and cryosections were prepared on a cryotome CM 3050S (Leica 
Microsystems, Wetzlar) and dried at 40°C overnight. Before staining, cryosections 
were fixed in acetone at 4°C for 10min. 
 
2.3.2 Immunohistochemistry 
Dewaxed and postfixed paraffin sections were incubated 10 min in boiling 10 mM 
citrate buffer pH 6.0 to damask antigen eptopes and then washed 5 min with PBS. For 
the epitope-demasking in F4/80 staining or CD3 staining, paraffin sections were 
incubated in 0.1% Trypsin (SIGMA Type II) solution (with 0.1% CaCl2, pH7.8) 
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30mins at 37°C or in 1mM EDTA pH8.0 for 10mins at 100°C respectively. For frozen 
section no epitope-demasking was required. Unspecific protein binding and 
endogenous peroxidases were saturated by a 20 min incubation in Quenching buffer 
(1 % BSA, 0.3 % H2O2 in PBS). After 3 times PBS washing (1 min each) at RT, the 
sections were incubated with the primary antibody diluted in DAKO diluent (DAKO, 
Hamburg) in a humid chamber for 1hour at RT or overnight at 4°C. After 3 times PBS 
washing (2 min each) the sections were incubated with the HRP-coupled or 
AP-coupled secondary antibody in a humid chamber for 1 hour at RT followed by 
another 3 times PBS washing. Colour-reaction was performed with peroxidase 
substrate kit HistoGreen (Linaris, Wertheim-Bettingen) or alkaline phosphatase kit III 
(Vector laboratory, Linaris) to produce green or blue color. The nuclei were 
counterstained with Nuclear Fast Red. For HistoGreen staining which produces 
water-soluble colour, the sections had to be dehydrated (3 times 30 sec 100% ethanol, 
2 times 30 sec xylene at RT) before mounting with Entellan (Merck). For Irga6 and 
F4/80 or CD3 double staining, Irga6 was stained first with 165/3 and HRP-coupled 
secondary antibody using 1ml 0.5% AEC (SIGMA) N,N’-dimethylformamide mixed 
with 19ml 50mM Acetate pH5.2 and 3µl 30%H2O2 as peroxidase substrate, and the 
sections were then incubated in PBS for 1h to quench the residue H2O2 before F4/80 
or CD3 was stained with AP-coupled secondary antibody using alkaline phosphatase 
kit III mentioned above. Samples were analysed using Zeiss Axioplan II microscope 
(Zeiss, Jena) equipped with SPOT RT slider digital camera (Diagnostic instruments).  
 
2.3.3 Immunofluorescence 
Fixed cryosections were washed with PBS and fixed in 3% paraformaldehyde for 20 
min at room temperature. Cells were permeabilized with 0.1% saponin and blocked 
with 3% BSA (Roth) for 1h at RT. The cells were then incubated with the primary 
antibody diluted in blocking buffer for 1 h in a humid chamber, washed, incubated 
with the secondary antibodies with DAPI, washed again and mounted with with 
Prolong Gold antifade reagent (Invitrogen) and sealed with nail polish. The cells were 
analyzed using a Zeiss (Oberkochen, Germany) Axioplan II fluorescence microscope 
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equipped with a cooled charge-coupled device camera (Quantix; Photometrix, Tucson, 
AZ).  
 
2.3.4 In situ hybridization 
The templates for the probe were amplified from the vector pGW1H-IIGP1 using 
Irga6 antisense primer (5’-CGGGGAAGTCATAGTGACAA-3’) and sense primer 
(5’-GGATCAGGGAAGTCCAGCTT-3’) cloned into the vector pGEM-T-easy 
(Promega). The templates for the sense and antisense probes were then amplified 
including either the promoter of the Sp6- or T7-RNA-polymerase. The RNA-probes 
were synthesized using the proper RNA-polymerase and labelled with DIG using the 
DIG labelling reaction mix (Roche) and then purified by ethanol precipitation. 
After dewaxing and postfixation, paraffin embedded sections of mice liver were 
digested with Proteinase K (10 µg/ml in 0.1 M Tris pH 7.5) for 10 min at 37°C, which 
was stopped by incubation in 0.2% glycine in PBS for 10 min at RT. Sections were 
then washed (2 times PBS, once 0.2 N HCl then once PBS) and positively charged 
amino acids were blocked by incubation in 0.1 M triethanolamine pH 8.0, 0.25% 
acetic acid anhydrate. After washing with PBS and H2O the samples were incubated 
for 2 hours at 70°C with prehydridization buffer (50% formamide, 5x SSC pH 7.0, 1x 
Denhardt’s solution, 0.1% Tween20). 1-5 µl of the proper probe was preheated to 
70°C mixed with 50 µl prehybridization buffer and 2 µl yeast tRNA (final 
concentration 0.1 mg/ml) and put on ice immediately. 55 µl of the hybridization 
solution was added on the slide, covered with a coverslip and incubated in humid 
chamber overnight at 70°C. After hybridization the slides were first washed 3 times 
for 30 min at 70°C with Solution I (50% formamide, 5x SSC pH 7.0, 1% SDS) and 
then 3 times for 30 min at 65°C with Solution II (50 % formamide, 2x SSC pH 7.0, 
0.2% SDS), which was followed by 3 times washes (5 min each) at RT with MAB 
(100 mM maleic acid, 150 mM NaCl, 0.1% Tween20, 2 mM Levamisole, adjust to pH 
7.5 with NaOH). The slides were then blocked for 2-3 hours at RT with 1% blocking 
reagent (Roche) in MAB before application of Anti-Digoxigenin-AP Fab fragments 
(Roche) (1:4000 in MAB/block) in a humid chamber at 4°C overnight. The sections 
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were then washed with MAB (3 times 10 min and 3 times 30 min at RT) and 3 times 
10 min with NTMT (100 mM Tris pH 9.5, 50 mM MgCl2, 100 mM NaCl, 2 mM 
Levamisole, 0.1% Tween20). BM purple substrate (Roche) with 2 mM Levamisole 
was used for the colour reaction which took 2 to 5 days. When the staining was 
finished the slides were washed with H2O and mounted with Kaiser’s glycerine 
(Merck). Note that all the solutions were made with DEPC H2O and glassware were 
baked to avoid RNase contamination.  
 
2.3.5 Laser Microdisseciton (LMD) 
Mice liver were taken and snap-frozen in liquid nitrogen. 6 µm thick cryosections 
were cut using a cryotome CM 3050S (Leica Microsystems, Wetzlar) and sections 
were put on PALM MembraneSlides (P.A.L.M. Microlaser Technologies, Bernried), 
which was covered with a PEN membrane. Consecutive sections were cut and all odd 
numbered sections were on one slide (named ‘A’) and the adjacent even numbered 
sections were on another slide (named ‘B’). Slides were then fixed for 20 min at 
-20°C in 70 % ethanol and then washed with H2O for 5 min. ‘B’ slide was stored at 
-80°C and ‘A’ slide was then stained for Irga6 with 165/3 using histogreen substrates. 
Pictures of Irga6 focal expression were taken. ‘B’ slide was then taken out and only 
counter-stained with Nuclear Fast Red, dehydrated by an ethanol series (70%, 96%, 
100% each step 2 min) and dried for 10 min at 50°C. Irga6 focal expression was 
found by comparison to the photos of adjacent sections on ‘B’ slide, and expression 
foci were cut with laser beam of lower power but high focus using the Laser 
Microdissection (LMD) equipment of the Institute for Pathology (University Clinic, 
Köln) consisting of an Interface Microbeam Mini laser (P.A.L.M Microlaser 
Technologies) and an Axiovert 135 microscope (Zeiss, Jena). The cut samples were 
collected in a small drop (less than 1µl) of mineral oil in the cap of LPC Microfuge 
tubes (P.A.L.M. Microlaser Technologies). 
Total RNA from the dissected samples was extracted using the RNeasy Micro kit 
(QIAGEN), using the 10fold amount of carrier RNA and the RNA was eluted in the 
smallest possible volume (12 µl). cDNA was made with 8µl of total RNA using the 
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Superscript First-Strand Synthesis System for RT-PCR kit (Invitrogen, Karlsruhe).  
 
2.4. Cell biology 
2.4.1 Mammalian cell line culture 
L929 mouse fibroblasts, and TIB-75 hepatocytes (Martens et al., 2004) were cultured 
in IMDM supplemented with 10% FCS (Sigma-Aldrich, Deisenhofen, Germany), 2 
mM L-glutamine (Invitrogen Life Technologies, Eggenstein, Germany), 1 mM 
sodium pyruvate (ICN, Eschwege, Germany), 100 U/ml penicillin (Invitrogen Life 
Technologies), and 100 µg/ml streptomycin (Invitrogen Life Technologies). Cells 
were induced with mouse IFN-γ (Cell Concepts, Umkirch, Germany) at a 
concentration of 200 U/ml for 24 hours.  
 
2.4.2 Mouse hepatocytes isolation and culture 
Hepatocytes were isolated from liver using a two-step liver perfusion method 
(Modified from Klaunig et al., 1981). Mice were anaesthetized with 2-5 ml Avertin 
(kindly provided by Prof. Jens Brüning, Köln) and injected with 100µl Heparin-Na 
(5000IU/ml). Mice were then dissected and liver portal vein was canulated and 
perfused with prewarmed (37°C) Krebs-Ringer-Buffer (KRB) (115 mM NaCl, 5.9 
mM KCl, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 1.2 mM Na2SO4, 2.5 mM CaCl2, 25 
mM NaHCO3, 10 mM glucose) at a flow rate of 3ml/min for 30 mins. Subsequently 
prewarmed 50ml KRB with 1mM EDTA was used for perfusion followed by100ml 
KRB with 0.5mM CaCl2 and 0.05% collagenase (SIGMA) at the same flow rate. 
Hepatocytes were then liberated from liver capsule, filtered through 100µm gauze and 
cell suspension was washed 2 times at 4°C first with washing buffer (1xHanks buffer, 
0.5% BSA, 10mM HEPES pH7.65) at low speed (50g) and then 2 times with 
DMEM/Ham’s F12 1:1 Medium. Cells were then preseeded for 15min on collagen 
coated plates and transferred to other collagen coated plates for culture for several 
days. Note: All buffers and gauze were sterilized and great care should be taken when 
handing the cells to avoid high mortality.  
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2.4.3 Immunofluorescence for cells 
Cells were washed with PBS and fixed in 3% paraformaldehyde for 20 min at room 
temperature. Cells were permeabilized with 0.1% saponin and blocked with 3% BSA 
(Roth) for 1h at RT. The cells were then incubated with the primary antibody diluted 
in blocking buffer for 1 h in a humid chamber, washed, incubated with the secondary 
antibodies with DAPI, washed again and mounted with with Prolong Gold antifade 
reagent (Invitrogen) and sealed with nail polish. The cells were analyzed using a Zeiss 
(Oberkochen, Germany) Axioplan II fluorescence microscope equipped with a cooled 
charge-coupled device camera (Quantix; Photometrix, Tucson, AZ).  
 
2.5. T. gondii. passage and infection 
Tachyzoites from T. gondii strain ME49 were maintained by serial passage in confluent 
monolayers of human foreskin fibroblasts (HS27, ATCC). Following infection of 
fibroblasts, 3 days later parasites were harvested from the culture supernatant and 
purified from host cell debris by differential centrifugation (5min at 50 g, 15 min at 
500g). Parasites were resuspended in medium and immediately used for inoculation of 
host cells.  
Murine primary hepatocytes were either left untreated or stimulated with IFN-γ (R&D 
Systems, Minneapolis, Minnesota, United States) at 200 U/ml for 24 h prior to infection. 
For determination of T. gondii growth via uptake of [3H]-uracil, hepatocytes were 
inoculated with T. gondii at different multiplicity of infection (MOI). After 48 h of 
incubation, cultures were labeled with 1lCi/well [3H]-uracil (Hartmann Analytical) for 
an additional 24 h. The amount of incorporated uracil, directly proportional to the 
parasite growth, was determined by liquid scintillation counting. For immunostaining, 
hepatocytes were inoculated with T. gondii at a MOI of 10 for 2 h. Extracellular 
parasites were then removed by extensive washing with PBS and cells were fixed. 
Vacuoles containing intracellular parasites were identified by immunostaining for the T. 
gondii dense granule protein GRA7 that is associates with the intravacuolar network 
and the PV membrane. The immunostaining protocol is as described in 2.4.3.  
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2.6. Promoter analysis 
All available public databases were screened with the Basic local alignment search 
tool BLAST (Altschul et al., 1990) for ESTs of Irga6 sequences. These included the 
databases of NCBI (http://www.ncbi.nlm.nih.gov), ENSEMBL 
(http://www.ensembl.org). Sequence alignments were performed with Vector NTI and 
edited manually. Shading of alignments and the amino acid identity and similarity 
matrix were conducted with GeneDoc (Version 2.6.002) (http://www.nrbsc.org). The 
region 500bp upstream of the transcription start point were designated as the putative 
promoter regions and screened for transcription factor binding sites. Putative 
conserved transcription factor binding sites in the promoters of Irga6 were identified 
using ConSite (http://www.phylofoot.org) (Sandelin et al., 2004) and confirmed 
manually.
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3. Reseults 
 
3.1. Irga6 is constitutively expressed in mouse tissues 
The well established view in the field that IRG proteins are expressed under the tight 
regulation of IFNs has been fully accepted. There are however, a few reports of 
constitutive expression of IRG proteins in mouse tissues (Collazo et al., 2001; Taylor 
et al., 1996). Nevertheless a systematic and quantitative search for constitutive 
expression of IRG in vivo is still missing. In order to examine whether there are 
constitutive expression of IRG proteins in vivo, several quantitative experiments were 
performed here to determine the expression of Irga6 as well as Irgm3 in a variety of 
mouse tissues. 
 
3.1.1 Irga6 has high and constant level of constitutive expression in mouse liver 
It has been described by Boehm and colleague that in uninfected mouse liver, IIGP1 
(Irga6) gene had insignificant, if any, basal expression, whereas upon Listeria 
monocytogenes infection the IIGP1 (Irga6) expression was induced to an extremely  
 
 
 
Figure 5. Inducibility of IIGP1 (Irga6) in different mouse strains upon infection with L. 
monocytogenes. As shown by Northern blot analysis of liver RNA, mice were infected with 
one-tenth of the LD50. Livers were isolated 24 h postinfection. Ten micrograms of total RNA was 
loaded per lane. lanes 1 and 2 C57BL/6 mice; lanes 3 and 4, IFN-gR0/0 mice; lanes 5 and 6, 
TNFRp55-/- mice; lanes 1, 3, and 5, uninfected control mice. GAPDH hybridization is shown as a 
loading control.  (modified from Boehm et al., 1998) 
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high level and the induction was totally IFN-γ dependent (Fig. 5) (Boehm et al., 1998). 
Later on however, it was observed that in uninfected mouse liver Irga6 protein had 
relatively high level of expression which was comparable to that in IFN-γ-induced 
L929 cells. In order to examine whether there was constitutive expression of Irga6 in 
liver, northern blot analysis using almost the same setup as that of Boehm et al. was 
performed with IFN-γ-induced or uninduced L929 cells as control (Fig. 6). 
 
 
 
Figure 6. Irga6 has strong constitutive expression in mouse liver on RNA level. Northern blot 
analysis of Irga6 expression in mouse liver was carried out. WT (C57BL/6J) or IFN-γ receptor 
knock out (IFN-γR-/-) mice were infected with Listeria monocytogenes at LD50 for 24 hours. Total 
RNA was extracted from infected (+) and uninfected (-) tissues. L929 cells unstimulated (-) or 
stimulated (+) with IFN-γ (200U/ml) for 24 hours were used as control. The total RNA was 
subjected to northern blot. The Irga6 ORF was labeled by [α-32P]-dCTP as probe. GAPDH was also 
detected as loading control. The signal intensity was quantified by phosphorimager and 
Autoradiography was performed. The histogram presents relative units of Irga6 signal after 
normalization to GAPDH signal. (modified from Jia Zeng Master Thesis, 2003) 
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Total RNA extracts from liver tissues of WT or IFN-γ receptor knock out mice 
infected with Listeria monocytogenes. Murine fibroblast cell line L929 stimulated or 
unstimulated by IFN-γ was used as control. The Irga6 ORF was chosen as probe for 
detecting Irga6 mRNA. After normalization to GAPDH signals, which served as a 
loading control, a significant level of Irga6 expression in uninfected liver was 
detected while there was no expression in unstimulated L929 cells. The Irga6 
expression in uninfected liver was almost three times higher than that in IFN-γ 
stimulated L929 cells. In the infected liver, however, this resting expression rose more 
than 13 fold, which is well known due to in vivo massive production of IFN-γ. For 
uninfected IFN-γ receptor knock out mice, there was still a significant level of Irga6 
expression and this expression was only slightly increased when the mice were 
infected (Fig. 6). The quantitative northern blot clearly demonstrated that Irga6 had a 
strong constitutive RNA expression in liver and this expression was not very much 
influenced by IFN-γ. 
Secondly, western blot was carried out to determine if this RNA expression is 
translated into protein. Liver tissues of baby (3, 4 days) and adult (4, 6 weeks) mice 
from different litters were ground in liquid nitrogen and lysed in RIPA buffer. Protein 
lysates were analyzed using Irga6 monoclonal antibody 10D7 in western blot. Indeed 
Irga6 showed a very strong protein expression, which judging by the Irga6 signal 
intensity normalized to the loading control calnexin, was even higher than that in 
IFN-γ stimulated L929 cells (Fig. 7). The Irga6 expression in liver was also very 
stable, as seen from the constant level of expression in livers from all the mice 
individuals of different ages and litters. Irgm3 was also tested here, which exhibited a 
similar expression profile in liver as Irga6 but at a much lower expression level. Irgm3 
western blot exhibited 3 bands and the intensity of each band varies between 
constitutive expression in liver and induced expression in L929 cells, for which we do 
not have an explanation yet (Fig. 7).  
In conclusion, in liver Irga6 (also Irgm3) does have high constitutive expression both 
on RNA and protein level and this expression is almost independent on IFN-γ. 
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3.1.2 Irga6 constitutive expression in liver has general and focal patterns 
To analyze the distribution of Irga6 constitutive expression, in situ hybridization was 
carried out. Fixed C57BL/6 mouse liver were embedded in paraffin and cut into 6µm  
 
 
 
Figure 7. Irga6 has strong constitutive expression in mouse liver on protein level. Western blot 
analysis of Irga6 expression in mouse liver was made. Livers from CB20 baby mice (3 or 4 days) 
and adult mice (4 or 6 weeks) were first ground in liquid nitrogen, weighed and lysed in RIPA 
buffer. L929 cells stimulated (+) with IFN-γ (200U/ml) for 24 hours were used as positive control. 
Loading for liver lysates is 100µg/lane and for L929 is 5,000cells/lane. Irga6 mAb 10D7 and 
anti-Irgm3 mAb 168120 were used for detecting respective proteins. Calnexin was also probed as a 
loading control. (modified from Jia Zeng Master thesis, 2003) 
Figure 8. Irga6 has general and focal expression pattern in mouse liver. In situ hybridization 
analysis of Irga6 expression in mouse liver was performed. Fixed C57BL/6 adult mice liver were 
embedded in paraffin and cut into 6µm sections. DIG-labeled single stranded RNA sense and 
anti-sense probe was made by in vitro transcription using the 5´ part of Irga6 ORF (1-490bp) as 
template. The hybridized RNA probe was detected by anti-DIG antibody, and visualized by color 
reaction catalyzed by alkaline phosphatase (AP) coupled to the antibody using BM purple (Roche) 
as substrate. Pictures were taken using light microscopy (10x10, ZEISS Axiophot). 
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sections. DIG labeled RNA probe was made by in vitro transcription using the 5´ part 
of Irga6 ORF as template. The positive hybridization signal was visualized by color 
reaction catalyzed by alkaline phosphatase (AP) coupled to anti-DIG antibody using 
BM purple (Roche) as substrate. The anti-sense probe revealed an overall expression 
of Irga6 mRNA expression in the liver and in addition there was very intense focal 
expression, which was normally sparsely dispersed (Fig. 8).  
 
 
 
Immunohistochemistry method was also applied to detect the expression pattern of 
Irga6 protein. Paraffin sections of mouse liver were stained with both Irga6 antiserum 
165/3 and mAb 10D7 (green). In contrast to liver from Irga6-/- mouse, WT liver 
presented a very strong overall protein expression of Irga6 in both antibodies’ staining. 
Figure 9. Irga6 has general and focal expression pattern in mouse liver. Immunohistological 
analysis of Irga6 expression in mouse liver was made. C57BL/6 WT and Irga6-/- adult mice liver 
were embedded in paraffin and cut into 6µm sections. Irga6 antiserum 165/3 and mAb 10D7-FITC 
was used for immunostaining. The secondary antibody for 10D7-FITC was against FITC to avoid 
unspecific binding by anti-mouse secondary antibody. The antibody specific binding was visualized 
by a green color reaction catalyzed using a Horseradish peroxidase (HRP) substrate Histogreen. 
Counter staining of nucleus (red) was done by nuclear fast red (NFR). Pictures were taken using 
light microscopy (10x10, ZEISS Axiophot). 
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Also extremely intensive Irga6 focal staining could be observed, which normally had 
very clear-cut boundaries and took the shape of patches (Fig. 9). 
Both in situ hybridization and immunohistochemistry demonstrated that in liver Irga6 
is constitutively expressed in two distinct patterns, overall general expression and 
intensive focal expression. 
 
3.1.3 Irga6 has constitutive expression in many mouse tissues 
Western blot analysis of different mouse tissues was carried out. Various mouse 
tissues including liver, heart, skin, spleen, intestine, thymus, lung, testis, kidney and 
brain were lysed in RIPA buffer and protein lysates were then subjected to western 
blot analysis. Irga6 was also expressed in many other tissues.  
 
 
Judging by the Irga6 signal normalized to loading control calnexin, the tissue that 
expressed highest level of the Irga6 was the liver and the heart was the tissue that had 
the second highest expression level. Spleen, skin, intestine and thymus expressed 
relative fewer Irga6. Lung, kidney and testis had only very low Irga6 expression. 
Finally the brain did not have any Irga6 expression. Irgm3 was also examined using 
Figure 10. Irga6 is constitutively expressed in many mouse tissues in western blot. Western 
blot analysis of Irga6 expression in several mouse tissues was made. Liver, heart, skin, spleen, 
intestine, thymus, lung, testis, kidney, brain were first ground in liquid nitrogen, weighed and then 
lysed in RIPA buffer. L929 cells stimulated (+) by IFN-γ (200U/ml) for 24 hours were used as 
positive control. Loading for all tissue lysates is 50µg/lane except for skin, for which it was 
150µg/lane. For L929 the loading is 5,000cells/lane. Irga6 mAb 10D7 and anti-Irgm3 mAb 168120 
were used for detecting respective proteins. Calnexin was also probed as loading control. (modified 
from Jia Zeng Master Thesis, 2003) 
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the same set-up and the expression level was found to be very low. With an 
over-exposure of the film, Irgm3 expression in tissues other than liver could be 
visualized and exhibited the expression profile is very similar to that of Irga6 (Fig. 
10).  
 
 
The distribution of Irga6 expression was also investigated by immunohistochemical 
methods for several mouse tissues. Paraffin sections of mouse kidney, heart, spleen 
and thymus were stained for Irga6 by 165/3 (green). In contrast to Irga6-/- mouse 
Figure 11. Irga6 is constitutively expressed in many mouse tissues. Immunohistochemical 
analysis of Irga6 expression in several mouse tissues was made. C57BL/6 WT and Irga6-/- adult 
mouse kidney, heart, spleen and thymus were embedded in paraffin and cut into 6µm sections. 
Irga6 was stained by mAb 10D7 (green). Counter staining (red) was done with nuclear fast red 
(NFR). Frames and arrows showed enlarged images (10x20). Pictures were taken using light 
microscopy (10x10, ZEISS Axiophot). 
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tissues, WT tissues all had strong Irga6 protein expression in specific patterns. In 
kidney, Irga6 expression was detected as small round patches and each such patch 
covered kidney tubule wall cells from several different tubules; in heart Irga6 
expression took the shape of enlongated patches, which obviously consisted mainly of 
heart muscle cell; in spleen most Irga6 were expressed in the red pulp; in thymus the 
expression was mainly detected in the thymus medulla (Fig. 11).  
Therefore, Irga6 is expressed not only in liver but also in many other tissues. Liver is 
the tissue with most abundant Irga6 expression. In kidney, even though the Irga6 total 
expression level is not among the highest, the expression is very concentrated in well 
defined pattern, which can be easily quantified. Hence, the following expression study 
was mostly focused on liver and kidney. 
 
3.2 Interferons show different influences on constitutive expression of Irga6 in 
different tissues 
IRG proteins were discovered because they are massively induced by interferons. To 
determine whether the constitutive expression of IRG proteins is dependent on 
interferons, interferon receptor deficient mice were analyzed. 
Ten mouse tissues, including liver, heart, skin, spleen, intestine, thymus, lung, testis, 
kidney and brain, from type I, type II interferon single receptor knock out and the 
double knock out mice were obtained. Tissue lysates containing equal amount of 
protein were subsequently subjected to western blot analysis. Judging by the Irga6 
signal intensity normalized to the loading control calnexin, it was observe that in 
different tissues the Irga6 expression displayed different dependency on interferons. 
Interferons had almost no influence on the Irga6 expression in liver and heart, since 
neither tissues from single interferon receptor knock out mice showed any decrease in 
expression, and the double knock out displayed only a little bit, if any, expression 
reduction (Fig. 12).  
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Figure 12. Irga6 constitutive expression in different mouse tissues was influenced 
differentially by interferons. Western blot analysis of Irga6 expression in IFNR knock out mouse 
tissues was carried out. Type I interferon receptor knock out (AR), type II interferon receptor knock 
out (GR), the double knock out (AGR) mice and WT 129sv mice were obtained. Organs indicated 
were taken from 4 mice of the double knock out and 2 mice of each single knock out. Organs were 
first ground in liquid nitrogen, weighed and then lysed in RIPA buffer. L929 cells unstimulated (-) 
or stimulated (+) by IFN-γ (200U/ml) for 24 hours were used as control. The loading for all tissue 
lysates is 150µg/lane except for liver, which had 80µg/lane. The loading of L929 cells is 
5,000cells/lane. Irga6 mAb 10D7 and anti-Irgm3 mAb 168120 were used for detecting respective 
proteins. Calnexin was also probed as loading control. (modified from Jia Zeng Master Thesis,
2003) 
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In spleen, kidney and skin however, the Irga6 expression was much down-regulated in 
either single interferon receptor knock out tissues and to an even greater extend in the 
double knock out (Fig. 12). In the case of thymus, lung, intestine and testis, the 
expression of Irga6 in the WT tissues was quite low and the decrease in the interferon 
receptor knock out was also rather mild.  
In brief, Irga6 expression in liver and heart seems not to be a response to interferons, 
whereas, kidney, skin and spleen have a more interferon-sensitive Irga6 expression. 
 
3.3 Irga6 has two transcriptional forms using 2 distinct promoters 
In liver the high level of universal expression of Irga6 that is not IFN-inducible, 
strongly suggested that this expression might be tissue-specific, for instance under the 
control of a liver-specific promoter. The Irga6 gene is known to consist of a long 
coding exon and two short 5’ exons called exon1A and exon1B, which are 
alternatively used together with the 3’ exon to produce two forms of Irga6 transcripts 
(Fig. 13A). The putative promoter regions of both these two 5’ short exons contain 
type I and II interferon regulatory elements.  
To define the promoter regions for Irga6 1A and 1B more accurately, a screen for 
Irga6 ESTs with the furthest 5’ end through the database was conducted. Two such 
ESTs were found, namely BY157974 for 1A and BI657093 for 1B. The putative 
transcriptional starting point defined according to these ESTs for 1A and 1B is exactly 
the same as formerly reported (Beckpen et al., 2005).  
Genomic sequences of 500bp upstream of the putative transcriptional starting points 
were taken as putative proximal promoters for Irga6 1A and 1B, which were then  
extensively analyzed using an online software, CONSITE, which can search 
transcription factor binding sites for a given sequence utilizing known consensus 
sequences, (http://mordor.cgb.ki.se/cgi-bin/CONSITE/), as well as manually seeking 
by comparison to published consensus binding sequences. As previously published, in 
Irga6 1A promoter there are two ISRE and three GAS sites, whereas in 1B promoter 
only one ISRE and one GAS sites (Fig. 13B). ISRE and GAS are classical type I and 
type II interferon responding elements and the existence of which explains the 
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inducibility of Irga6 by interferons (Beckpen et al., 2005). An elaborated search for 
 
 
 
 
liver specific transcription factor binding sites, however, revealed that Irga6 1B but 
not 1A promoter possesses multiple hepatocyte nuclear factor (HNF) binding sites, 
specifically HNF4, HNF1, HNF3 and HNF6 (Table 3). HNF1 and HNF3 binding sites 
were detected by CONSITE, and HNF4 and HNF6 binding sites were attained by 
manual comparison to published consensus binding sequences (Jiang and Sladek, 
1997; Sladek et al. 1990; Lemaigre et al., 1996; Sladek et al., 1990; Samadani & 
Costa 1996). These HNF binding sites seem to be segregated into two clusters, one 
close to the transcriptional starting point and the other one 200bp further upstream, 
both of which have HNF4 sites. Clustering of various hepatocyte nuclear factors was 
Figure 13. Irga6 gene has two transcriptional forms using distinct promoters. A scheme of 
Irga6 gene structure (A) was shown. The length of 1A, 1B and the coding exon is 103 bp, 184 bp 
and 2233 bp. The 5’ starting point of each exon was define by ESTs with the furthest 5’ end, 
namely BY157974 for 1A and BI657093 for 1B. The distance between 1A and 1B is around 6.5 kb; 
between 1B and coding exon is around 7.0 kb. The scheme is to scale. A scheme for Irga6 1A and 
1B promoter (500bp) and putative transcription factor binding sites was also shown (B). The 
scheme is not to scale. The binding sites on the negative strand were marked by ‘(-)’.  
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reported to be a characteristic feature of many hepatocyte specific promoters (Schrem 
et al. 2002; Jiang & Sladek 1997; Lemaigre et al. 1996; Samadani & Costa 1996). 
Furthermore, HNF4 has been established to be of vital importance in being the first to 
bind the promoter and subsequently initiating recruitment of other hepatocyte nuclear 
factors and the transcriptional initiation machinery. Therefore, Irga6 1B promoter is 
strongly indicated to be a hepatocyte specific promoter.  
 
 
 
3.4. IRG proteins are constitutively expressed in primary hepatocytes 
Irga6 expression in liver was examined more closely by immunofluorescence 
technique. Liver cryosections was stained for Irga6 by its antiserum 165/3. Irga6 
displayed clear cytoplasmic localization in liver parenchymal cells (Fig. 14).  
Table 3. Putative HNF sites used by Irga6 1B promoter. In putative Irga6 1B promoter HNF-1 
and HNF-3β sites were found electronically using an online promoter analysis tool, CONSITE, 
(http://mordor.cgb.ki.se/cgi-bin/CONSITE/). HNF-4 and HNF-6 sites were found manually by 
comparison with published consensus binding sequences. The sequences of putative binding sites 
were compared to the consensus sequences and the position of the sequences upstream the putative 
transcriptional starting point was marked. Identical bases are shaded in black. Binding sites on the 
negative strand were marked by ‘(-)’. D=A/G/T, H=A/C/T, N=A/C/G/T, W=A/T, K=G/T, Y=C/T. 
                                                   Results 
 48
 
 
3.4.1 IRG proteins are expressed constitutively in murine primary hepatocyte 
To establish that Irga6 is truly expressed in liver parenchymal cells, murine primary 
hepatocytes were isolated by a two-step in situ liver collagenase perfusion technique 
(modified from Klaunig et al., 1981). The liver of an anaesthetized mouse was 
perfused in situ through the hepatic portal vein by collagenase buffer and the primary 
hepatocytes were then isolated and cultured on collagen coated plates. The cells were 
then lysed at different time points and analyzed by western blot with IRG antibodies. 
Primary hepatocytes immediately after isolation had almost the same level of Irga6 
expression as liver (Fig. 15). The expression in the primary cells kept constant after 6 
hours of culture. 12 hours post isolation, however, the amount of Irga6 showed a 
slight decrease, and then dropped very drastically at 24 hours and finally got further 
reduced to an extremely low level from 2 days on. The rapid drop of gene expression 
in isolated primary cells is known to be the typical behavior for many hepatocyte 
specific genes (Clayton and Darnell, 1983; Clayton et al., 1985). Not surprisingly, 
IFN-γ could induce Irga6 expression in primary hepatocytes to a much higher level.  
Figure 14. Irga6 is likely to be expressed in liver parenchymal cells. Immunofluorescence 
analysis of Irga6 expression in liver was carried out. C57BL/6 adult mouse liver was cut into 6µm
cryo-sections and stained for Irga6 by its antiserum 165/3 (red). Staining without primary antibody 
(-165/3) was made as negative control. Alexa-546 coupled to secondary antibody was visualized by 
fluorescence microscopy. DAPI (blue) stained the nuclei. Pictures were taken using fluorescence 
microscopy (10x63, ZEISS Axiophot).
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The expression of other IRG proteins was also tested. Irgm3 expression in the liver 
was quite low compared to IFN-γ stimulated L929 cells and the expression in primary 
hepatocytes was even lower, which did not change with time. Irgb6 and Irgm1 had 
similar expression profile as Irga6 but at much lower level, namely, they were all 
expressed in liver at a moderate level and also had comparable amount of expression 
in primary hepatocytes, which stayed at least after 3 hours culture and dropped 24 
hours post isolation (Fig. 16). All the IRG proteins in primary hepatocytes were able 
to be stimulated by IFN-γ to a very high level.  
In conclusion, Irga6 has high level of expression in primary hepatocytes, which acts 
as the major contributor to constitutive expression in liver. Similarly, Irgb6, Irgd and 
Irgm1 also have constitutive expression in liver, which is also conferred primarily by 
Figure 15. Irga6 are constitutively expressed in murine primary hepatocytes. Western blot 
analysis of Irga6 expression in murine primary hepatocyte was made. C57BL/6 murine primary 
hepatocytes were isolated by a two-step in situ liver collagenase perfusion technique. The liver of 
an anaesthetized mouse was perfused in situ through the hepatic portal vein first by Ca2+ and Mg2+
free Hank’s buffer and then by collagenase medium. The detached hepatocytes were then liberated, 
washed, and cultured in DMEM/Ham’s F12 (1:1) medium supplemented with ITS+ and 
dexamethasone on collagen coated plates. Primary hepatcytes were harvested either immediately 
after isolation (0h) or at indicated hours (h) or days (d) post isolation. IFN-γ (200U/ml) stimulation 
for 24 hours was made for primary cells (24h+), L929 cell (+), TIB73 cells (+) as positive controls 
and unstimulated L929 (-) and TIB-73 (-) were used as negative control. Liver lysates (250µg/lane) 
were also included. Irga6 mAb 10D7 (A) were applied and Calnexin was also probed as loading 
control.
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their expression in hepatocytes. Irgm3 is expressed only at very low level in liver and 
also in hepatocytes. All the IRG proteins examined here are able to be induced 
strongly by IFN-γ in primary hepatocytes. 
 
 
 
3.4.2 Constitutively expressed Irga6 is localized mainly in ER but not in Golgi in 
murine primary hepatocytes 
IFN-γ induced Irga6 is mainly an ER and cytosolic protein (Martens et al., 2005). To 
test the localization of Irga6 constitutively expressed in primary hepatocytes, 
immunofluorescence microscopy was applied. In primary hepatocytes cultured for 6 
hours after isolation without IFN-γ stimulation, double staining for Irga6 and ER 
marker, calnexin or Golgi marker, Gm130, clearly confirmed that Irga6 is expressed 
as an ER but not Golgi protein (Fig. 17). Therefore, constitutively expressed Irga6 
Figure 16. Some other IRG proteins are also constitutively expressed in murine primary 
hepatocytes. Western blot analysis of IRG proteins expression in murine primary hepatocyte was 
made. Murine primary hepatocytes were isolated cultured and harvested either immediately after 
isolation (0h) or at indicated hours (h) post isolation. IFN-γ (200U/ml) stimulation for 24 hours was 
made for primary cells (24h+), L929 cell (+), TIB73 cells (+) as positive control and unstimulated 
L929 (-) and TIB-73 (-) were used as negative control. Liver lysates (250µg/lane) were also 
included. mAb 168120 (anti-Irgm3 Ab) (A), goat antiserum A20 (anti-Irgb6 Ab), rabbit antiserum 
L115 (anti-Irgm1 Ab) (B) were applied to detect respective proteins. Calnexin was also probed as 
loading control. “*” indicated crossreacting bands of the Irgb6 antiserum. 
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displays the same localization as the IFN-γ stimulated protein. 
 
 
 
3.5. IRG protiens participate in IFN-γ induced resistance against Toxoplasma 
gondii infection 
3.5.1 IFN-γ mediates growth inhibition of Toxoplasma gondii in murine primary 
hepatocytes 
The replication of intracellular parasite Toxoplasma gondii can be strongly inhibited 
by IFN-γ in many cell types (Martens et al., 2005; Könen-Waisman unpublished 
results). To investigate the IFN-γ inhibition effect on T. gondii growth in primary 
hepatocytes, T. gondii proliferation assay was carried out. Murine primary 
hepatocytes were isolated and stimulated with IFN-γ for 24 hours or left untreated 
prior to T. gondii infection. The growth of T. gondii was monitored by uracil 
incorporation assay. Primary hepatocytes infected by T. gondii using different 
multiplicity of infection (MOI) all showed similar IFN-γ restriction of the parasite 
Figure 17. Irga6 constitutively expressed in primary hepatocytes is localized to ER. 
Immunofluorescence analysis of Irga6 expression in murine primary hepatocyte was made. 
C57BL/6 murine primary hepatocytes were isolated, cultured for 6 hours, fixed and permeablized 
for staining. Double staining using either Irga6 mAb 10E7 (green) and calnexin rabbit antiserum 
(red) or Irga6 rabbit antiserum 165/3 (red) and anti-GM130 mAb (green) was performed. 
Alexa-546 (red) coupled secondary antibody against rabbit antiserum and FITC (green) coupled 
secondary antibody against mAb were used. Cell nuclei were stained by DAPI (blue). Pictures were 
taken using fluorescence microscopy (10x63, ZEISS Axiophot). 
                                                   Results 
 52
proliferation in primary hepatocytes in a dose dependent manner (Fig. 18). IFN-γ does 
confer primary hepatocytes resistance against T. gondii.  
 
 
 
 
3.5.2 Both constitutively expressed and IFN-γ stimulated Irga6 accumulated 
around Toxoplasma gondii vacuoles in murine primary hepatocytes 
In IFN-γ stimulated cells IRG proteins can accumulate around T. gondii, which has 
been taken as one of the major known IFN-γ induced intracellular resistant 
mechanisms against the parasite in murine cells (Martens et al., 2005).  
By immunofluorescence staining for Irga6 and GRA7, which is a T. gondii 
marker(Bonhomme et al., 1998; Fischer et al., 1998), in freshly isolated primary 
hepatocytes infected by T. gondii, the accumulation of the GTPase at parasitophorous 
vacuoles (PVs) could be clearly detected (Fig. 19A). About 10% of total intracellular 
parasites were coated by Irga6 in primary cells unstimulated by IFN-γ and upon 
IFN-γstimulation, however, the proportion of Irga6 positive vacuoles rose up to 40% 
(Fig. 19B).  
Figure 18. IFN-γ mediates growth inhibition of T. gondii in murine primary hepatocytes. T.
gondii proliferation assay of primary hepatocyte was carried out. Murine primary hepatocytes were 
isolated and stimulated with IFN-γ (1-200 U/ml) for 24 hours or left untreated prior to T. gondii
(ME49) inoculation by different multiplicities of infection (MOI). After 48 hours of infection, 
cultures were labeled with 1µCi/well [3H]-uracil for additional 24 hours. The amount of 
incorporated uracil, which is directly in proportion to T. gondii growth (Pfefferkorn and 
Pfefferkorn, 1977), was determined by liquid scintillation counting. Percentage of growth was 
normalized to that of cells uninfected by T. gondii. 
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Irgb6, Irgd, Irgm3 did not accumulate at PVs in primary hepatocytes without IFN-γ 
treatment whereas upon IFN-γ induction they could relocalize to the vacuoles (Fig. 
20A). The accumulation of IRG proteins at the PVs was observed to have an inclusion 
relationship, namely IRG proteins family members relocate to the PVs in a sequential 
Figure 19. Constitutive and IFN-γ stimulated Irga6 proteins accumulate around T. gondii PVs 
in murine primary hepatocytes. Immunofluorescence analysis of Irga6 accumulation at T. gondii
vacuoles in murine primary hepatocytes was made. C57BL/6 murine primary hepatocytes were first 
isolated and either stimulated (+IFN-γ) for 12 hours with IFN-γ (200U/ml) or left untreated and 
cultured for 3 hours (-IFN-γ). The cells were inoculated with T. gondii (ME49) by MOIx3 for 2 
hours, fixed and permeablized for staining. Double stainings (A) for Irga6 with mAb 10E7 (green) 
and GRA7 with anti-GRA7 mAb (red) was made. Nuclei were stained by DAPI (blue). Histograms 
present percentage of Irga6 positive vacuoles in the total intracellular T. gondii vacuoles (B). The 
mean of two or three independent counts representing 200-400 vacuoles were always made for 
each value. Pictures were taken using fluorescence microscopy (10x63, ZEISS Axiophot). 
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order (Könen-Weisman and Khaminets unpublished results). This is also true here for 
primary hepatocytes. Under IFN-γ treated condition, almost all the Irga6 postive 
vacuoles were also Irgb6 positive only a few (3%) vacuoles are Irga6 positive but 
Irgb6 negative and vice versa. All Irgd positive vacuoles were also positve for Irga6, 
but the former accounted for only 40% of the latter (Fig. 20B).  
In summary, in primary hepatocytes in contrast to other murine IRG proteins, which 
accumulate at PVs only upon IFN-γ induction, constitutively expressed Irga6 alone 
can coat vacuoles though with a lower proportion. The coating of PVs by IRG 
proteins exhibits an inclusion relationship as well. 
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3.5.3 Toxoplasma gondii vacuoles coated by Irga6 maturate in murine primary 
hepatocytes 
T. gondii vacuoles accumulating IFN-γ induced Irga6 undergo morphology changes, 
namely from smooth to rough and then to disrupted, implying a gradual disruption of 
PVs most probably by IRG proteins, which leads to the deterioration of the parasites 
(Martens et al., 2005). 
Here the morphology change of Irga6 coated vacuoles was examined both for IFN-γ 
stimulated and unstimulated primary hepatocytes. In unstimuted cells, 90% of T. 
gondii PVs coated by constitutive Irga6 were smooth and there were however already 
10% rough and 1% disrupted vacuoles (Fig. 21). The proportion of rough and 
disrupted vacuoles increased significantly in IFN-γ stimulated cells. Interestingly 
under IFN-γ stimulated condition the Irgd positive vacuoles showed faster maturation, 
namely higher proportion of rough vacuoles. 
 
 
Figure 20. IFN-γ stimulated IRG proteins accumulate around T. gondii PVs in murine 
primary hepatocytes. Immunofluorescence analysis of IRG proteins accumulation at T. gondii
vacuoles in murine primary hepatocytes was made. C57BL/6 murine primary hepatocytes were 
isolated, stimulated (+IFN-γ) for 12 hours with IFN-γ (200U/ml) prior to inoculation with T. gondii
(ME49) by MOIx3 for 2 hours. The cells were then fixed and permeablized for staining. Several 
double stainings were performed (A): Irga6 with 10E7 (green) and Irgb6 with goat antiserum A20 
(red); Irga6 with 10E7 (green) and Irgd with rabbit antiserum 2078 (red); Irg6 with 165/3 (red) and 
Irgm3 with mAb 168120 (green). Arrows indicate a vacuole that is both Irga6 and b6 positive; 
filled arrow heads indicate a vacuole that is only Irga6 positive; empty arrow heads indicate a 
vacuole that is only Irgb6 positive. Nuclei were stained by DAPI (blue). Histograms present 
percentage of Irga6 positive vacuoles in the total intracellular T. gondii vacuoles and the ratio of 
Irgb6 positive or Irgd positive vacuole to Irga6 positive vacuole in primary hepatocyte with 
(+IFN-γ) or without (-IFN-γ) IFN-γ stimulation. The mean of two or three independent counts 
representing 200-400 vacuoles were always made for each value. Pictures were taken using 
fluorescence microscopy (10x63, ZEISS Axiophot). 
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3.6. Irga6 focal expression in liver and kidney exploits interferon pathway 
3.6.1 The focal expression of Irga6 in liver and kidney is developmentally 
regulated 
Except for general constitutive expression, Irga6 also has intense focal expression in 
liver. Immunohistochemical staining of liver sections establishes two types of Irga6 
focal expression.  
Figure 21. Toxoplasma gondii vacuoles coated by Irga6 maturate in murine primary 
hepatocytes. Immunofluorescence analysis of the morphology of T. gondii vacuoles coated by IRG 
proteins in murine primary hepatocyte was made. C57BL/6 murine primary hepatocytes were first 
isolated and either stimulated (+IFN-γ) 12 hours with IFN-γ (200U/ml) or left untreated and 
cultured for 3 hours (-IFN-γ). The cells were inoculated with T. gondii (ME49) by MOIx3 for 2 
hours, fixed and permeablized for staining. Double stainings were made for Irga6 with 10E7 
(green) and Irgd with rabbit antiserum 2078 (red). Smooth, rough and disrupted vacuoles (A) were 
counted for Irga6 and Irgd under IFN-γ stimulated and unstimulated conditions. Diagram represents 
percentages of each type of vacuole for Irga6 and Irgd (B). Two or three independent counts 
representing 200-400 vacuoles were always made for each staining. 
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One type is represented by a group of liver parenchymal cells, which express much 
higher amounts of Irga6 than the surrounding cells forming clear-cut boundaries and 
take the shape of patches. The other kind of focal expression exhibits exactly the same 
features except that they always have in the center a group of small mononuclear cells, 
which are Irga6 negative. Those mononuclear cells have small condensed nuclei and 
few cytoplasm, characteristic of lymphocytes or leukocytes (Fig. 22A). In the 
Figure 22. Irga6 has two types of focal expression in liver and the focal expression in liver and 
kidney is developmentally regulated. Immunohistochemical analysis of Irga6 expression in 
mouse liver was performed (A). C57BL/6 adult mice liver paraffin section (6µm) was stained for 
Irga6 with 165/3 (green). Nucleus counter stain was in red with NFR. Picture was taken using light 
microscopy (10x40). Quantification of Irga6 focal expression in liver from mice of different ages 
was made. Liver and kidney from C57BL/6 new born mice and mice aged as indicated after birth 
were embedded in paraffin and sections (6µm) were cut through the whole organ with an interval of 
300 µms between adjacent sections. The sections were then stained for Irga6 with 165/3 and Irga6 
expression foci were counted separately within a microscopic view field (10x10, ZEISS Axiophot). 
Each value in the histogram represents the mean of 20 such counts for organs from 2 mice of each 
age. 
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following study, the former is named “patch or P” and the latter “cored patch or CP”.  
In order to test how early Irga6 focal expression occurs in liver, liver from C57BL/6 
mice of different ages were examined. Irga6 expression foci (including P and CP) on 
stained liver sections were counted under the microscopic view field (10x10 Zeiss 
Axiophot). In newborn and very young (1 week) mouse liver there were only very 
few Irga6 expression foci. The number of foci started to rise in 2-week liver and 
reached a constant level (10-12 foci/microscopic view field) from 3 weeks on. Irga6 
expression in kidney was also quantified in the same way showing a similar profile 
(Fig. 22B). The Irga6 focal expression seems to be developmentally regulated in liver 
and kidney. 
 
3.6.2 Irgm3 is coexpressed at Irga6 expression foci in liver and kidney.  
To determine whether other IRG proteins are also expressed at Irga6 expression foci 
in liver, immunohistological staining of mouse liver for Irgm3 was performed. Since 
an Irga6 focal expression staining on the liver section represents the cross-section of a 
group of parenchymal cells in a ball shape, in consecutive liver sectioning the 
cross-section of the same group of cells should be present at the same position on 
adjacent liver sections. Consecutive serial liver paraffin sections were cut. Two 
adjacent serial sections were probed by Irga6 and Irgm3 antibodies respectively, and 
the same position on Irgm3 stained section, where on the adjacent section Irga6 
expression foci were localized, was monitored. While Irgm3 had almost no general 
expression in liver, it did co-express at Irga6 expression foci, strongly indicating that 
the focal expression originates from interferon activation (Fig. 23). Interestingly, 
intensive expression of Irgm3 could also be detected in a certain type of small cells of 
unknown origin. In kidney Irgm3 was also expressed at Irga6 expression foci.  
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3.6.3 Irga6 cored patch in liver and patch in kidney is dependent on interferons. 
IFN-γ deficient mice were examined for the purpose of defining the relationship 
between Irga6 focal expression and IFN-γ. Liver and kidney paraffin sections from 
C57BL/6 WT and IFN-γ-/- mice were stained for Irga6 and the focal expression was 
quantified. In contrast to WT mouse liver, though IFN-γ-/- mouse liver did have Irga6  
Figure 23. Irgm3 is coexpressed at Irga6 expression foci in liver and kidney. Analysis of Irgm3 
coexpression with Irga6 in mouse liver and kidney was made with immunohistochemical methods. 
C57BL/6 adult mice liver and kidney paraffin sections (6µm) were prepared in a consecutive serial. 
The two adjacent serial sections were probed by Irga6 (serial 1, green) and Irgm3 (serial 2, green)
antibodies respectively. Frames show enlarged images. Arrow indicates a small cells expressing 
Irgm3. Nucleus counter-staining was NFR (red). Pictures were taken using light microscopy 
(10X10, ZEISS Axiophot) 
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patches, there were no cored patches. Irga6 expression foci also disappeared in the 
knock out kidney (Fig. 24). Therefore, Irga6 cored patches in liver and patches in 
kidney had an IFN-γ origin. 
Analysis of interferon receptor knock out mouse kidney was undertaken to verify the 
role of interferon activation in Irga6 focal expression. Kidney paraffin sections from 
129/sv WT, type I interferon receptor knock out (IFNAR), type II interferon receptor 
knock out (IFNGR), and double receptor knock out (IFNAGR) mice were stained for 
Irga6 and the focal expression was quantified. WT 129/sv mouse kidney had Irga6 
expression foci, though at lower amount. In both single interferon receptor and double 
receptor knock out kidney there were no expression foci at all, establishing the effect 
of interferon on Irga6 focal expression (Fig. 25). 
Figure 24. Irga6 liver cored expression patches and kidney expression patches disappear in 
IFN-γ-/- mice. Immunohistochemical analysis of Irga6 expression in IFN-γ-/- mice liver and kidney 
was made (A). Adult mice liver and kidney from C57BL/6 WT and IFN-γ-/- mice were embedded in 
paraffin and sections (6µm) were cut through the whole organ with an interval of 300 µms between 
adjacent sections. stained for Irga6 (green). Frame shows enlarged images. Nucleus 
counter-staining was NFR (red). Irga6 patch, cored patch in liver and patch in kidney were counted 
separately within a microscopic view field (10x10, ZEISS Axiophot). Each value in the histogram 
represents the mean of 20 such counts for organs from 2 mice of each genotype (B). Pictures were 
taken using light microscopy (10X10, ZEISS Axiophot). 
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Figure 25. Irga6 focal expression is absent in interferon receptor knock out mice kidney. 
Immunohistochemical staining of Irga6 expression in interferon receptor knock out mice kidney
was made (A). Paraffin sections (6µm) of adult mice kidney from 129/sv WT, type I interferon 
receptor knock out (IFNAR), type II interferon receptor knock out (IFNGR), and double receptor 
knock out (IFNAGR) mice were cut through the whole organ with an interval of 300 µms between 
adjacent sections. The sections were stained for Irga6 (green) and the focal expression was 
quantified. Nucleus counter-staining was NFR (red). Irga6 patch in kidney were counted for each 5 
sections from 2 kidneys of 2 mice. (B). Pictures were taken using light microscopy (10X40, ZEISS 
Axiophot). 
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3.6.4 Irga6 focal expression is eliminated in STAT-1-/- but not gp130-/- liver and 
kidney 
In order to further prove the importance of interferon to Irga6 focal expression, 
STAT-1 deficient mice were examined. STAT-1 is a transcription factor used both by 
type I interferon and type II interferon signaling, the deletion of which leads to the 
blockage of both interferon pathways (Durbin et al., 1996; Meraz et al., 1996). 
Paraffin sections of liver and kidney from C57BL/6 WT or STAT-I-/- mice were 
stained for Irga6 and the focal expression was quantified (Fig. 26). While the general 
expression of Irga6 in liver was intact, all the Irga6 focal expression is completely 
abolished both in liver and in kidney. The expression of Irga6 in heart was also tested 
and showed no change in the knock out mice (Data not shown).  
IL-6 is a pro-inflammatory cytokine secreted by T cells and macrophages to stimulate 
immune response to trauma and pathogen invasion (van der Poll et al., 1997). Gp130 
is the essential signaling receptor component and the deficiency in gp130 abolished 
IL-6 signaling (Yoshida et al., 1996). gp130-/- mice were sampled and exhibited 
normal Irga6 expression in liver and kidney (Fig. 27).  
In conclusion, Irga6 focal expression is dependant on interferon signaling pathways. 
The Irga6 cored patch in liver and patch in kidney are of IFN-γ origin, whereas the 
Irga6 patch is induced most probably by type I interferon. 
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Figure 26. Irga6 focal expression is eliminated in STAT-1-/- mice liver and kidney. 
Immunohistochemical staining of Irga6 expression in STAT-1-/- mice liver and kidney was made 
(A). Paraffin sections (6µm) of adult mice liver and kidney from C57BL/6 WT and STAT-1-/- mice 
were cut through the whole organ with an interval of 300 µms between adjacent sections and 
stained for Irga6 (green) and the focal expression was quantified. Nucleus counter-staining was 
NFR (red). Irga6 patch, cored patch in liver and patch in kidney were counted separately within a 
microscopic view field (10x10, ZEISS Axiophot). Each value in the histogram represents the mean 
of 20 such counts for organs from 2 mice of each genotype (B). Pictures were taken using light 
microscopy (10X10, ZEISS Axiophot).
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3.7. Two transcriptional forms of Irga6 are expressed differentially in liver 
Irga6 gene has 2 alternative transcriptional forms, namely 1A which has an interferon 
promoter and 1B which is expressed under a hepatocyte specific promoter. It is 
tantalizing to speculate that the general expression in liver be mainly 1A form of Irga6, 
whereas the focal expression mainly make use of the 1B form. To test this speculation, 
detailed investigation of the expression of Irga6 1A and 1B forms in liver was carried 
out using Laser Microdissection (LMD) and quantitative Real-Time PCR (qRTPCR) 
Figure 27. Irga6 focal expression is normal in gp130-/- mice liver and kidney. 
Immunohistochemical staining of Irga6 expression in gp130-/- mice liver and kidney was made (A). 
Paraffin sections (6µm) of adult mice liver and kidney from C57BL/6 WT and gp130-/- mice were 
cut through the whole organ with an interval of 300 µms between adjacent sections and stained for 
Irga6 (green) and the focal expression was quantified. Nucleus counter-staining was NFR (red).
Irga6 patch, cored patch in liver and patch in kidney were counted separately within a microscopic 
view field (10x10, ZEISS Axiophot). Each value in the histogram represents the mean of 20 such 
counts for organs from 2 mice of each genotype (B). Pictures were taken using light microscopy 
(10X10, ZEISS Axiophot). 
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techniques. 
Cryo-sections of liver were stained for Irga6 and the expression foci were cut by laser 
and collected for RNA extraction and RTPCR (Fig. 28). Since direct immunostaining 
of the sections always resulted in very low RNA yield, the following method was 
developed. C57BL/6 mouse liver were cut in to consecutive cryo-sections and 
numbered (e.g. 1, 2, 3….). The odd-numbered sections were stained for Irga6 and 
photos of Irga6 expression foci were taken. The even-numbered sections were then 
only counter stained with NFR and the position of Irga6 focal expression was defined 
by using photos of Irga6 expression foci from adjacent odd-numbered sections as 
reference. Subsequently the positioned Irga6 expression foci on the even-numbered 
sections were cut using Laser Microdissection technique.  
 
 
 
3.7.1 Irga6 1B form is more abundant in liver 
In the first place, Irga6 1A and 1B transcripts level in mouse liver was determined by 
quantitative Real-Time PCR. Same amount of liver cDNA was used as template and 
Irga6 1A and 1B exon specific 5’ primers were designed, which together with a 
common 3’ primer on the coding exon are capable of detecting the 2 transcripts, as 
shown by the melting curves (Fig. 29A). Though it is not easy to compare precisely 
the amount of 2 products, since they originated from different primer pairs, with a 
Figure 28. rga6 expression foci were collected by Laser Microdissection. Immunohistochemical 
staining of Irga6 expression in C57BL/6 mice live was made. Cryo-sections (6µm) of adult mice 
liver were stained for Irga6 (green) Nucleus counter-staining was NFR (red). Laser microdissection 
(PALM) was carried out using sharp focused low power laser to cut the Irga6 expression foci. 50 of 
such laser sections were collected by pulse of high power laser strike onto a drop of oil in a 500µl 
tube cap and stored in liquid nitrogen for further RNA extraction.  
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difference of 5 to 6 in CP values (5 to 6 cycles), 1B transcript should be much more 
abundant than 1A in whole liver (Fig. 29B).  
 
 
 
 
3.7.2 Irga6 1A form is remarkably more abundant in Irga6 expression foci in 
liver 
Irga6 1A and 1B expression levels were compared between Irga6 expression foci (F) 
and the non-foci (NF) using Real-Time PCR. More than 50 Irga6 foci and comparable 
amount of non-foci were cut and collected (Laser Microdissection, PALM). Total 
RNA was extracted, and cDNA was synthesized.  
Real-Time PCR (SYBR Green I LightCycler, Roche) demonstrated that while Irga6 
1B form in foci was only slightly (2 times) higher than non-foci, 1A in the foci is 
Figure 29. Irga6 1B form is more abundant in liver. A. Scheme of primers design for detection 
of 2 different transcript forms of Irga6. 5’ primers specific for Irga6 1A and 1B exon together with 
one common 3’ primer specific for the coding exon generate specific products for both forms of 
transcripts. B. Quantitative Real-Time PCR analysis of Irga6 1A and 1B transcripts in liver was 
performed. Liver total RNA was isolated (RNAeasy Mini, QEAGEN), and transcribed into cDNA 
(Superscript II system, Invitrogen). Equal amounts of liver cDNA were taken as template for
Real-Time PCR (SYBR Green I Light Cycler, Roche) using 1A and 1B specific primers. For each 
gene 3 replicate reactions were made. SYBR green I fluorescence history versus cycle number of 
1A and 1B (A) was used to determine ct values (B left). Fluorescence changing rate versus 
temperature--the melting curve (B right) showed the specificity of the products.  
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increased up to 30 folds compared to non-foci (Fig. 30A and C). The melting curve of 
1A in Irga6 non-foci at the 1A specific melting temperature always displayed a very 
small peak, which was barely higher than the noise peak (Fig. 30 B). Final products of 
both 1A foci and non-foci PCR reaction were cloned and sequenced. It turned out that 
only 10% of the 1A non-foci products were specific for 1A, whereas 100% of the 1A 
foci products were specific (Fig. 30D). Since the calculation was based on 
fluorescence of total products, the ratio for 1A level of foci to non-foci should be 
much higher than 30. 
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3.7.3 Irga6 1A form in cored patch is expressed at similar level as in patch in 
liver 
 
 
 
Figure 31. Irga6 1A form expression level in cored patch is similar to that of patch in liver.
Quantitative Real-Time PCR was performed to determine Irga6 1Atranscript level in Irga6 1A 
cored patch and patch in liver. More than 50 Irga6 cored patch and comparable number of 
non-cored patch laser sections were collected (Laser Microdissection, PALM). Total RNA was 
extracted (RNAaese Micro, QIAGEN), and cDNA was synthesized (Superscript II system, 
Invitrogen). Real-Time PCR (SYBR Green I Light Cycler, Roche) was carried out using patch (P, 
red) or non-patch (CP, blue) cDNA as templates, looking for Irga6 1A as target genes. GAPDH was 
also included as reference gene. For each gene 2 replicate reactions were made in every 
experiment. SYBR green I fluorescence history versus cycle number of 1A (A) was used to 
determine ct values. ∆ct (NF-F) values for target and reference genes were calculated. The ratio of 
CP/P of 1A (B) were determined then using PFAFFL method (Pfaffl et al., 2001).  
Figure 30. Irga6 1A form is much more abundant in Irga6 expression foci in liver. Quantitative 
Real-Time PCR was performed to determine Irga6 1A and 1B transcripts level in Irga6 1A 
expression foci or non-foci in liver. More than 50 Irga6 foci and comparable number of non-foci 
laser sections were collected (Laser Microdissection, PALM). Total RNA was extracted (RNAaesy
Micro, QIAGEN), and cDNA was synthesized (Superscript II system, Invitrogen). Real-Time PCR 
(SYBR Green I Light Cycler, Roche) was carried out using foci (NF, red) or non-foci (F, blue) 
cDNA as templates, looking for Irga6 1A and 1B as target genes. GAPDH was also included as 
reference gene. For each gene 2 replicate reactions were made in every experiment. SYBR green I 
fluorescence history versus cycle number of 1A and 1B (A) was used to determine ct values. ∆ct 
(NF-F) values for target and reference genes were calculated. The primer efficiencies were 
determined by Real-Time PCR using template (liver cDNA) titration (Pfaffl, 2001). The ratio of 
F/NF of 1A and 1B (C) were determined then using PFAFFL method (Pfaffl et al., 2001). 
Histogram (C) represents the mean values of 2 independent experiments. Fluorescence changing 
rate versus temperature is the melting curve (B right) showing the specificity of the products (B 
right). Arrow points to 1A specific product, arrow head points to unspecific noise. 1A foci and 
non-foci products were ligated to pGEM-T Easy vector (Promega), transformed into E. coli. 
(DH5α). 20 clones were sequenced and percentage of 1A sequences were calculated (D).  
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Type I interferons were reported to be weaker inducers of IRG proteins (Carlow et al., 
1998; Taylor et al., 1996). To determine whether there are more Irga6 1A form in 
cored patch, expression levels of 1A were compared between Irga6 expression cored 
patch and patch. More than 50 Irga6 cored patch (CP) and comparable amount of 
patch (P) were cut and collected for Real-Time PCR. Irga6 1A expression in cored 
patch is only slightly higher than that of patch (Fig. 31).   
 
3.7.4 IFN-γ is expressed in Irga6 cored patch but not in patch in liver 
Semi-quantitative Reverse-Transcriptase PCR was performed searching for IFN-γ 
mRNA in both Irga6 cored patch and patch. cDNA from Irga6 cored patch and patch 
were used as template and Nest-PCR for IFN-γ was performed, using internal primer 
pairs within the PCR product of the first round PCR to do the second round PCR. 
Clearly IFN-γ mRNA could only be detected in cored patch (CP) but not in patch (P) 
(Fig. 32).  
 
 
 
 
 
 
 
Figure 32. IFN-γ is expressed in Irga6 cored patch but not in patch in liver. Semi-quantitative 
Reverse-Transcription PCR was performed to determine IFN-γ expression in Irga6 1A cored patch 
and patch in liver. More than 50 Irga6 cored patch and comparable number of non-cored patch laser 
sections were collected (Laser Microdissection, PALM). Total RNA was extracted (RNAaesy
Micro, QIAGEN), and cDNA was synthesized (Superscript II system, Invitrogen) as templates for 
IFN-γ Nest-PCR. 5’ Primer specific for IFN-γ exon1 (IFNG fw2) and 3’ primer (IFNG bw2) for 
exon 4 was designed for the first round of amplification of 45 cycles. The product length was 507 
bp, which was then taken as template for the second round of PCR of 45 cycles using another 5’ 
primer specific for exon 2 and 3 junction (IFNG sp2) and the same 3’ primer. The final product 
length is 332 bp. Liver cDNA (Liver) was also included and GAPDH was amplified as loading 
control. The sequencing of CP product demonstrated that the product is indeed IFN-γ. 
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3.8. T cells are essential for Irga6 cored focal expression in liver 
3.8.1 T cells and macrophages are present in the center of Irga6 cored focal 
expression in liver and kidney 
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In order to identify the sources of IFN-γ for Irga6 cored patch expression, the cell type 
composition of the “core” were analyzed. Double staining of C57BL/6 mouse liver 
paraffin sections were made for Irga6 (red) and CD3 (blue), which is a T cell marker, 
or Irga6 (red) and F4/80 (blue), which is a macrophage cell surface marker. Serial 
sections explicitly demonstrated that T cells were present in the center of Irga6 cored 
patch. T cells were found in the Irga6 expression foci in kidney as well (Fig. 33A). In 
addition macrophages were also localized to the “core” of Irga6 expression patch in 
liver and kidney (Fig. 33B).  
 
3.8.2 Irga6 cored patch expression in liver is eliminated in RAG-1-/- mice 
RAG-1-/- mice are genetic altered strains lacking T and B lymphcytes (Mombaerts et 
al., 1992). These mice were examined to establish the relationship of T cells to Irga6 
focal expression. Paraffin sections of C57BL/6 WT and RAG-1-/- mouse liver and 
kidney were stained for Irga6 (green) and the focal expression was quantified. No 
Irga6 cored patch expression was found in RAG-1-/- liver and the patch expression 
was reduced additionally (Fig. 34). Interestingly, kidneys from knock out mice were 
almost full of Irga6 expression foci, indicating an over-expression of interferon (Fig. 
34A).  
JHT mice are deficient of B cells because of the loss of functional H chain locus 
(Chen et al., 1993). Analysis of JHT mice showed normal presence of all types of 
Irga6 focal expression (Fig. 34). The number Irga6 cored patch liver and patch in 
kidney were elevated in the knock out mice.  
Figure 33. T cells and macrophages are present in the center of Irga6 cored expression in liver 
and kidney. Immunohistological double staining of mice liver and kidney was made for Irga6 and 
T cell or macrophage marker. Paraffin sections (6µm) of adult C57BL/6 mice liver and kidney were 
stained for Irga6 (red) with 165/3 and CD3 with anti-CD3 mAb (A, blue) or anti-F4/80 mAb (A, 
blue). For Irga6 and CD3 double staining, consecutive serial sections were made and arrows point 
to CD3 positive T cells. For detection of Irga6 the horseradish peroxidase substrate AEC was used 
and for CD3 or F4/80 the Alkaline Phosphotase Substrate Kit III (Vector, Linaris) was used. 
Pictures were taken using light microscopy (10X10, ZEISS Axiophot). 
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In brief, T cells are essential for Irga6 cored patch expression, which is most probably 
induced by IFN-γ secreted by T cells in the middle. 
 
3.9. Vβ8 Vα14 NK T cell is the major T cell population in Irga6 cored expression 
patch in liver 
In many immune responses, like the immune responses elicited by superantigens and 
many autoimmune diseases, there exist biased uses of certain subsets of T cell 
receptors. Therefore examination of TCR repertoire sometimes may reveal the nature 
of immune responses.  
 
3.9.1 T cell receptor Vβ8 subfamily is preferentially used by T cells in Irga6 cored 
expression patch in liver 
T cell receptor Vβ (TCR Vβ) usage was analyzed for T cells existing in the Irga6 focal 
expression cores. More than 50 Irga6 cored patches in liver were first collected by 
Laser Microdissection, and cDNA was then synthesized as template for Nested-PCR. 
The first PCR was carried out using Vβ consensus primer (DVB1S) as 5’ primer and a 
3’ Cβ primer (Cβ outer). The product was then taken as template for another round of 
PCR using another 3’ Cβ primer (Cβ inner) to produce fragments around 280 bp, 
which were then cloned and sequenced. The clones with TCR Vβ sequences were 
identified using an online tool IMGT/V-QUEST, which can identify Vβ sequences by 
comparing given sequences to those in the data base, (http://imgt.cines.fr/). T cells 
from cervical and mesenteric lymph nodes were used as control (Fig. 35A and B). In 
contrast to control T cell clones which exhibited a wide range of TCR Vβ distribution, 
Figure 34. Irga6 cored patch expression is eliminated in liver of RAG-1-/- but not JHT mice. 
Immunohistochemical staining of Irga6 expression in RAG-1-/- and JHT mice liver and kidney was 
made (A). Paraffin sections (6µm) of adult mice liver and kidney from C57BL/6 WT, RAG-1-/- and 
JHT mice were stained for Irga6 (green) with 165/3 and the focal expression was quantified.
Nucleus counter-staining was NFR (red). Irga6 patch, cored patch in liver and patch in kidney were 
counted separately within a microscopic view field (10x10, ZEISS Axiophot). Each value in the 
histogram represents the mean of 20 such counts for organs from 2 mice of each genotype (B). 
Pictures were taken using light microscopy (10X10, ZEISS Axiophot).
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including 8, 5, 14, 15, 2, 10, 11, all clones from Irga6 cored patch belonged to Vβ8 
subfamilies, especially Vβ8.2 which was the most abundant. This indicates that there 
was a biased TCR Vβ usage in Irga6 cored patch (Fig. 35C).  
 
 
 
Figure 35. TCR Vβ8 subfamily is preferentially used by T cells in Irga6 cored expression 
patch. More than 50 Irga6 cored patches were collected by laser sections, total RNA was extracted, 
and cDNA was synthesized as template for Nested-PCR. The first PCR was carried out by Vβ 
consensus primer (DVB1S) as 5’ primer and a 3’ Cβ primer (Cβ outer). The second round of PCR 
used the same 5’ primer and another 3’ Cβ primer (Cβ inner) (A). T cells from cervical and 
mesenteric lymph nodes were used as control. The length of final products was around 280bp (B). 
The products were subsequently ligated to pGEM-T Easy vector (Promega), transformed into E. 
coli. (DH5α) and clones were sequenced. The sequences were compared to classical TCR Vβ
sequences online using IMGT/V-QUEST (http://imgt.cines.fr/), and the clones with a sequence 
identity of more than 95% to known Vβ sequences were identified as Vβ clones. In total 132 and 68 
Vβ clones for control T cells and Irga6 cored patch respectively were identified and the percentage 
of each Vβ subfamily was displayed by the histogram(C).  
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Figure 36. TCR Vβ8 clones of Irga6 cored patch had variety of junctions. A. Sequences of 
identified TCR Vβ8 clones of Irga6 cored patch were compared, classified into different junction 
types and the number of clones for each type are listed. Dβ, Jβ subfamily names are also labeled 
(‘ - ‘ means not identified) and TCR Vβ-N(D)N-Jβ junctional sequences are shown. Dβ elements 
flanked by the template independent (N) sequences are underlined. ‘Short’ indicates Vβ8 clones 
that are too short to have complete junctional regions. B. Sequence alignment of identified TCR 
Vβ8 clones of Irga6 cored patch. Sequences shaded in black are identical sequences. Sequences
shaded in gray or without shade show sequences that are not identical.  
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Detailed analysis of the sequences of clones from Irga6 cored patch revealed that they 
possessed various junctions. For example, there were 4 J regions and 5 junction types 
for Vβ8.2 clones (Fig. 36A). Sequence alignments demonstrated that they also had 
differences in length (Fig. 36B).  
 
3.9.2 T cells carrying Vβ8 TCR exist in Irga6 cored expression patch in liver 
To prove that Vβ8 TCR bearing T cells are really present in the center of Irga6 cored  
 
 
 
  
 
patch in liver, immunostaining for Vβ8 TCR in mouse liver was carried out. C57BL/6 
mice livers were cut into consecutive cryo-sections and immunostaining for Irga6 and 
Figure 37. T cells bearing Vβ8 TCR are present in the center of Irga6 cored patch in liver. 
Immunohistochemical analysis of Vβ8 TCR expression in mouse liver was carried out. 
Cryo-sections (6µm) from C57BL/6 adult mice liver were prepared in a consecutive serial. The two 
adjacent serial sections were probed by Irga6 mAb 165/3 (1, green) and TCR Vβ8 mAb name (2, 
blue) respectively. Frames show enlarged images. Arrows indicate T cells expressing Vβ8 TCR. 
Nucleus counter-staining was NFR (red). Pictures were taken using light microscopy (10X10, 
ZEISS Axiophot). 
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anti-Vβ8 TCR was made on two adjacent sections respectively. Comparison of the 
staining at the same position on the two sections demonstrated Vβ8 TCR positive T 
cells obviously existed right in the center of Irga6 cored patch (Fig. 37). 
 
3.9.3 T cell receptor Vα14-Jα18 is preferentially used by T cells in Irga6 cored 
expression patch in liver 
 
 
  
 
Figure 38. TCR Vα14-Jα18 is preferentially used by T cells in Irga6 cored expression patch.  
More than 50 Irga6 cored patches were collected by laser sections, total RNA was extracted, and 
cDNA was synthesized as template for Nested-PCR. The first PCR was carried out by Vα14
specific 5’ primer and a 3’ primer for Cα (Cα), and the second PCR was done using another 3’ 
primer for Cα (Cα nest) (A). T cells from cervical and mesenteric lymph nodes were used as 
control and the length of final products was around 280bp. GAPDH was used as loading control 
(B). The products were sequenced and the sequences were compared to classical TCR Vα 
sequences online using IMGT/V-QUEST (http://imgt.cines.fr/), and the clones with a sequence 
identity of more than 95% to known Vα sequences were identified as Vα clones. In total 40 and 71 
Vα clones for control T cells and Irga6 cored patch were identified respectively and the percentage 
of each Vα subfamily was displayed by the histogram (D). Alignment of Vα14 primer and the 
corresponding region on Vα11 was made (C).  
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Figure 39. T cells from Irga6 cored patch use invariant TCR Vα14-J18. A. Sequences of 
identified TCR Vα14 and 11 clones were compared, classified into different junction types and the 
number of clones for each type is listed. Vα and Jα subfamily names are also labeled and TCR 
Vα-N-Jα junctional sequences are shown. ’Short’ indicates Vβ8 clones that are too short to have 
complete junctional regions. B. Sequences alignment of identified TCR Vβ14 clones of Irga6 cored 
patch. Sequences shaded in black are identical sequences. Sequences shaded in gray or without 
shade show sequences that are not completely identical. 
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NKT cells are a lineage of T cells, which have a Vβ8 usage bias for TCRβ chain and 
also mostly an invariant Vα14-Jα18 TCR α rearrangement (Bendelac et al., 2007). 
Therefore, TCR Vα14 was analyzed in Irga6 cored patch.  
Irga6 cored patches in liver were first collected by Laser Microdissection, from which 
RNA was extracted and cDNA synthesized as template for Nested-PCR. The first 
PCR was carried out using Vα14 specific 5’ primer and a 3’ Cα primer (Cα). The 
product was taken as template for a second round of PCR using another 3’ Cα primer 
(Cα nest) to produce fragments around 220 bp, which were then cloned, sequenced 
and identified (Fig. 38A and B). 
It turned out that Vα positive clones fell into 2 groups, Vα14 and Vα11. Sequence 
comparison revealed that the Vα14 primer sequence has a quite high identity with one 
region of Vα11 (Fig. 38C). For Irga6 cored patch in liver 97% of the Vα clones are 
Vα14 and only 3% are Vα11. In the case of T cells, however, 100% of the clones are 
Vα11 (Fig. 38D). This indicates that the Vα14 T cells were much more concentrated 
in Irga6 cored patch.  
Detailed analysis of the sequences of clones from Irga6 cored patch demonstrated that 
they all share a common J segment, namely Jα18, in spite of which small variations of 
only 1 or 2 nucleotides right at the V-J junction could be observed (Fig. 39A). Clones 
from T cells that are only positive for Vα11 displayed a great variety of junctional 
types using 10 different Jα segments (Fig. 39B).  
 
 
 
 
Figure 40. T cells bearing TCR Vβ14 are more abundant in Irga6 cored expression patch. 
More than 50 Irga6 cored patches were collected by laser sections, total RNA was extracted, and 
cDNA was synthesized as template for Nest-PCR. The first PCR was carried out by 5’ primer 
specific for Vα14, 2, 8 or 17 and a 3’ primer for Cα (Cα), and the second PCR was done using 
another 3’ primer for Cα (Cα nest). T cells from cervical and mesenteric lymph nodes were used as 
control. GAPDH was used as loading control.  
                                                   Results 
 81
Several other TCR Vα members were also examined in the same context using 
RTPCR. For periphery T cells Vα 2, 8, 17 are among the most frequently used TCR 
Vα subfamilies (Yoshida et al., 2000b). The expression of these Vα subfamily 
members were tested for Irga6 cored patch and control T cells. TCR Vα 2, 8 had very 
strong expression for control T cells, which was very weak or almost absent for Irga6 
cored patch, and TCR Vα 17 also was expressed to a lesser extend for T cells but not 
at all for Irga6 cored patch (Fig. 40).  
In summary, NKT cells are most probably the major T cell type in Irga6 cored patch. 
 
3.10. Irga6 focal expression is not caused by bacteria and endotoxin 
3.10.1 Irga6 focal expression is intact in germ free mice  
In order to determine the causes of Irga6 focal expression Germ free mice, which are 
free of bacteria and common infectious viruses, were analyzed, (Wagner et al., 1959). 
Germ free (GF) mice and specific pathogen free (SPF) C57BL/6 mice were obtained 
from the Instituto Gulbenkian de Ciência (Portugal). Liver and kidney were cut into 
paraffin sections (6µm), stained for Irga6 (green) and Irga6 focal expression was then 
quantified (Fig 41). Surprisingly, Irga6 focal expression was present also in GF mouse 
liver and kidney. The Irga6 focal expression was even much elevated in GF kidney 
(Fig. 41B). GF mice from two other sources, Institut für Labortierkunde Uni. Zürich 
(Switzerland) and the Karolin's Institute (Sweden), were also examined, and in both 
cases the normal existence of Irga6 focal expression was also confirmed (Fig. 41C).  
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3.10.2 Irga6 focal expression persists in TLR pathway deficient mice 
Mice deficient in TLR pathway were examined to establish the possible relationship 
between Irga6 focal expression and endotoxins. C57BL/6 WT and TLR-2/4 double 
knock out or TLR-9-/- mice were obtained. Paraffin sections of liver and kidney form 
these mice were stained for Irga6 (green) and Irga6 focal expression was then 
quantified (Fig. 42). No significant differences could be detected between the WT and 
knock out mice.  
MyD88 is one of the most important adaptor proteins down stream in TLR signaling 
(Fitzgerald et al. 2001). MyD88-/- mice were also tested. C57BL/6 WT and MyD88-/- 
mouse liver paraffin sections were prepared and stained for Irga6 (green). Irga6 focal 
expression was also quantified. Again no big effect can be observed (Fig. 43).  
Figure 41. Irga6 cored patch expression exist in GF mice. GF and SPF mice from the Instituto 
Gulbenkian de Ciência (Portugal), Institut für Labortierkunde Uni. Zürich (Switzerland) and the 
Karolin's Institute (Sweden) were obtained. Paraffin sections (6µm) of liver and kidney were 
prepared from these mice. Immunohistochemical staining for Irga6 (green) was made (A and C) 
and the focal expression was quantified. Nucleus counter-staining was NFR (red). Frame show 
enlarged image (A). For Portugal tissues Irga6 patch, cored patch in liver and patch in kidney were 
counted separately within a microscopic view field (10x10, ZEISS Axiophot). Each value in the 
histogram represents the mean of 20 such counts for organs from 2 mice of each type (B). Pictures 
for mice from Portugal (10x10), Switzerland and Sweden (10x20) were taken using light 
microscopy (ZEISS Axiophot). 
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3.11 Irga6 expression after Listeria monocytogenes infection 
It is intriguing to learn how Irga6 expresses in Listeria infection. C57BL/6 mice were 
infected by Listeria monocytogenes and sacrificed at different time points and Irga6 
expression in liver and kidney was examined by western blot and 
immunohistochemistry.  
In contrast to liver inoculated by heat-killed Listeria monocytogenes, which had a 
comparable level of expression as uninfected liver in western blot, in liver infected by 
live bacteria, Irga6 expression was already much elevated 24 hours post infection and 
rose even higher in the following days. The situation was similar in the case of 
infected kidney (Fig. 44) 
Immunostaining of Irga6 of liver and kidney infected for 24 hours still exhibited 
normal pattern of Irga6 focal expression with a more intensive staining both for the 
general and focal expression. In livers infected for more than 2 days, Irga6 general 
expression was greatly elevated and focal expression disappeared consequently. 
Instead, huge unstained foci occurred, which started to appear from the second day on 
and accumulated in a greater number in the following days. The expression of Irga6 in  
Figure 42. Irga6 cored patch expression is not affected in TLR-2/4 double knock out and 
TLR-9-/- mice. C57BL/6 WT, TLR-2/4 double knock out and TLR-9-/- mice were obtained. From 
these mice liver and kidney paraffin sections (6µm) were cut through the whole organ with an 
interval of 300µm between 2 adjacent sections. Immunohistochemical staining for Irga6 (green)
was made (A) and the focal expression was quantified (B). Nucleus counter-staining was NFR 
(red). Irga6 patch, cored patch in liver and patch in kidney were counted separately within a 
microscopic view field (10x10, ZEISS Axiophot). Each value in the histogram represents the mean 
of 20 such counts for organs from 2 mice of each genotype (B). Pictures were taken using light 
microscopy (10X10, ZEISS Axiophot). 
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Figure 43. Irga6 cored patch expression is normal in MyD88-/- mice. C57BL/6 WT and 
MyD88-/- mice were obtained. From these mice paraffin sections (6µm) of liver and kidney were 
were cut through the whole organ with an interval of 300µm between 2 adjacent sections. 
Immunohistological staining for Irga6 (green) was made (A) and the focal expression was 
quantified (B). Nucleus counter-staining was NFR (red). Irga6 patch, cored patch in liver and patch 
in kidney were counted separately within a microscopic view field (10x10, ZEISS Axiophot). Each 
value in the histogram represents the mean of 20 such counts for organs from 2 mice of each 
genotype (B). Pictures were taken using light microscopy (10X10, ZEISS Axiophot). 
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infected kidney also started to become intensified 24 hours post infection and from 
the second day post infection on the whole kidney was overall filled with extremely 
intense Irga6 expression, indicating a strong overall IFN-γ response (Fig. 45).  
 
 
Figure 44. Irga6 expression in liver and kidney infected by listeria monocytogenes in western 
blot. Western blot analysis of Irga6 expression in liver and kidney infected by Listeria 
monocytogens was made. C57BL/6 adult mice were either infected by Listeria monocytogens at 
LD50 or inoculated by same amount of heat-killed bacteria or left untreated. Liver and kidney were 
taken at indicated time points post infection (p.i.), ground in liquid nitrogen, weighed and then 
lysed in RIPA buffer. L929 cells stimulated (+) by IFN-γ (200U/ml) for 24 hours were used as 
positive control. Irga6 mAb 10D7 was used for detecting protein expresion. Calnexin was also 
probed as loading control. 
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Figure 45. Irga6 expression in liver and kidney infected by listeria monocytogenes.
Immunohistochemical analysis of Irga6 expression in liver and kidney infected by Listeria 
monocytogens was carried out. Liver and kidney were embedded in paraffin and cut into 6µm 
sections and stained for Irga6 (green) by 165/3 antiserum. Nuclear counter-stain was NFR. Pictures 
were taken using light microscopy (10X10, ZEISS Axiophot). 
                                                   Discussion 
 91
4. Discussion 
 
IRG proteins are a family of IFN-inducible GTPases, which confer resistance to a 
varied group of bacterial and protozoan pathogens correlating to the resistance 
dependent on IFN-γ. The expression of IRG has been widely investigated and a 
consensus that IRG GTPases are expressed under the tight regulation of IFNs, has 
been reached. Our unexpected findings that IRG proteins do have significant 
constitutive as well as IFN-inducible expression in vivo, and in liver at least for one 
member, Irga6, achieved by selective usage of distinct alternative promoters, would 
not only change our current understanding of the expression pattern but also shed a 
new light on the resistance functions of this family of IFN-inducible GTPases. 
Peculiar Irga6 focal expression in liver as well as in kidney was also observed and 
proved to be induced by local production of IFNs. The production of IFN-γ that 
induces Irga6 focal expression in liver surprisingly represents the local activation of 
NKT cells even in the absence of microbial environment (germ-free mice). Even 
though the causes of this NKT cell activation are still elusive, we speculate that this 
stimulation of NKT cells may stand for an ongoing process required for the 
maintenance of peripheral NKT cell effector phenotype.  
 
4.1 IRG proteins are constitutively expressed in mice liver 
Previous analysis of expression for IRG proteins in vivo revealed a predominant IFN- 
esp. IFN-γ-dependent expression in liver, spleen or lung during infection with 
intracellular pathogens like Listeria monocytogenes, Toxoplasma gondii or 
Mycobacterium tuberculosis (Boehm et al., 1998; Collazo et al., 2001; Gavrilescu et 
al., 2004; Taylor et al., 2000). For instance, the mRNA expression of all the six 
well-known members of Irg genes could be induced to a very high level in the liver 
infected by Listeria monocytogenes in an IFN-γ dependent manner, but in the absence 
of infection there was no basal expression observed (Fig. 5) (Boehm et al., 1998). 
However, we observed that, when a proper control such as L929 cells induced with 
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IFN-γ was included in the same experiment setup, compared to the induced cells very 
high level of basal mRNA expression of Irga6 gene was discovered in uninfected liver 
(Fig. 6). The otherwise overlooked basal expression in uninfected liver was 
surprisingly high, much higher than that in the fibroblast cell line stimulated with 
IFN-γ. Furthermore this basal expression is only mildly decreased in animals deficient 
in both type I and type II interferon receptors (Fig. 12).  
Irgm3 gene expression has also not been detected in liver in a non-quantitative way 
(Taylor et al., 1996). Again, however, in an experiment quantitatively normalized to 
IFN-γ-induced L929 cells we could easily detect an expression of Irgm3 protein in 
liver, though in this case at a much lower level than in induced L929 cells (Fig. 7&16). 
Irgb6, Irgm1 and Irgd are all also expressed in the liver at a significant level, though 
the IFN influence on these GTPases are not yet tested (Fig. 16).  
The question rises why IFN-inducible resistance GTPases should be constitutively 
expressed in the liver? In the special case of Irga6, where the basal liver expression is 
extremely high, we have shown that the tissue specific expression in the liver and 
IFN-induction of Irga6 are independently controlled by distinct promoters.  
 
4.2 The expression of Irga6 in liver was under the control of alternative 
activation of distinct promoters  
The open reading frame of Irga6 gene is encoded on a single 3’ long exon behind two 
alternatively used 5’ exons, exon 1A and exon 1B that are spliced to the long conding 
exon producing two Irga6 transcripts (Fig. 13). The promoter region of Irga6 1A is a 
strong IFN-inducible promoter, containing 3 ISRE and 2 GAS sites, whereas Irga6 1B 
promoter is much weaker harboring only 1 ISRE and 1 GAS sites (Bekpen et al., 
2005). Our analysis of putative promoter binding sites in the promoter regions of both 
Irga6 transcripts led to the discovery of multiple hepatocyte nuclear factor binding 
sites only in the proximal promoter region of Irga6 1B (Fig. 13&14).  
Hepatocyte-specific gene transcription requires simultaneous binding of multiple, 
distinct hepatocyte nuclear factors (HNFs) to the gene regulatory region providing 
synergistic transcriptional activation (Fig. 46) (Costa et al., 2003). Among HNFs, one 
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of the most important is HNF4, which, interacting with multiple proteins that act at 
distinct steps during transcription (Green et al., 1998), can activate transcription by 
facilitating the assembly of transcription initiation machinery (Schrem et al., 2002). 
Similar to other hepatocyte-specific genes such as transthyretin (TTR) (Fig. 46), 
putative binding sites of multiple HNFs in Irga6 1B promoter region fall into two 
clusters, both of which include a HNF-4 site (Fig. 13&14), strongly suggesting that it 
is a hepatocyte specific promoter. Consistently, Irga6 was found to be expressed in 
freshly isolated primary hepatocytes at very high level, which was comparable to that 
in liver. Interestingly this expression decreased very rapidly when the primary cells 
were cultured for certain time (Fig. 15). It is well acknowledged that when 
hepatocytes are removed from the animal and cultured in vitro, the transcription rates 
of many liver-specific genes decrease dramatically, due to rapid dedifferentiation of 
primary hepatocytes (Clayton and Darnell, 1983; Clayton et al., 1985). The fast 
decline of Irga6 expression in primary hepatocytes is in line with our assumption that 
Irga6 constitutive expression in liver is driven by a tissue specific promoter.  
 
 
Systematic analysis of the expression of Irga6 1A and 1B transcript forms in liver and 
primary hepatocytes performed by Parvanova (Ph.D thesis), revealed that 1B 
transcript was exceptionally more aboundant (50 to 100 fold) than 1A both in normal 
Figure 46. Transcription factors that regulate expression of the TTR and FoxA2 genes and 
their binding sites. Schematically shown are the FoxA2 (HNF3β) and TTR promoter constructs 
and their corresponding transcription factors. Members of 4 different liver-enriched transcription 
factors HNF1, Foxa, HNF4, HNF6, and C/EBP (Samadani and Costa, 1996) and the growth factor 
inducible AP-1 rotein (Qian et al., 1995) bind the TTR regulatory regions. The strong affinity 
FoxA binding site (-106 to -96 bp) overlaps with the HNF6 binding site in the TTR promoter 
(Samadani and Costa, 1996). The TTR enhancer is also recognized by an uncharacterized 
ubiquitous factor (UF) and contains one FoxA binding site, which is selectively recognized by the 
FoxA2 isoform (Samadani et al., 1996). (Modified from Costa et al., 2003) 
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liver and primary hepaotcytes. Upon stimulation however, such as infection for liver 
or IFN-γ induction for primary hepatocytes, the Irga6 1A transcript was upregulated 
more than 1,000 fold whereas the 1B transcript was only slightly elevated (Parvanova, 
Ph.D thesis). These observations validated our speculation that the expression of Irga6 
in liver is controlled by differential activation of different promoters.  
 
 
Among the numerous IFN-regulated genes, only CIITA and ADAR1 were reported to 
modulate gene expression utilizing multiple promoters and alternative exon1 splicing 
to a shared exon2 (George et al., 2005; Muhlethaler-Mottet et al., 1997). The 
biological relevance of the expression regulation of ADAR1 gene by alternative usage 
of type I IFN-inducible promoter and embryonic specific promoter is not clear 
(George et al., 2005). In the case of CIITA however, distinct CIITA promoters control 
either MHC_II constitutive expression in dendritic cells and B lymphocytes, or 
IFN-γ-inducible expression in a variety of MHC-II-negative cell types 
(Muhlethaler-Mottet et al., 1997) (Fig. 47). Thus a hierarchy is involved in the control 
of the cellular, temporal and functional diversity of MHC-II expression by differential 
activation of different promoters of a single transactivator gene. Alternative promoters 
have also been identified in several other non-IFN-inducible eukaryotic genes 
Figure 47. Schematic representation of the complexity of promoterspecific control of CIITA and 
MHC-II expression. (Modified from Muhlethaler-Mottet et al., 1997)   
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(Ayoubi and Van De Ven, 1996; Schibler and Sierra, 1987). Their differential usage 
can afford an extra level of flexibility in the regulation of these genes, for example, 
one promoter can be functional in a given tissue or during a particular developmental 
stage.  
It is unlikely that Irga6 functions in such a way as CIITA or in a tissue- or 
developmental specific manner since Irga6 obviously does not serve as a 
transactivator nor a normal tissue- or developmental specific gene. Mice deficient for 
individual members of IRG GTPases have dramatic susceptibility phenotypes to many 
infectious intracellular bacteria and protozoa correlating well with the loss of IFN-γ 
dependent resistance in mice, implicating IRG proteins as IFN-inducible resistant 
factors (Collazo et al., 2001; MacMicking, 2004; MacMicking, 2005; Taylor et al., 
2000). Tissue-specific expression of resistant GTPases in the absence of IFN is 
possibly due to special immune milieu in liver. Liver is an organ of immune privilege, 
namely immune tolerance, since immunologically, the liver is an extreme 
environment, exposed to a constant flux of antigens and bacterial molecules from the 
intestine. As in the intestine, tolerance in such an environment may be preferable to 
immunity. However, the liver is also a favorable place of infection for many 
pathogens such as malarial parasite or Listeria (Crispe et al., 2006). Constant 
expression of resistance molecules such as immunity-related GTPases in the absence 
of IFNs may be a preferable solution to prepare liver cells in a state of greater 
competence in resistance to pathogens in such an immune tolerant environment.  
 
4.3 Constitutively expressed IRG proteins participate in cell-autonomous 
resistance to Toxoplasma gondii. in primary hepatocytes 
There is growing evidence favoring the idea that IRG proteins exert their resistance 
function in a cell-autonomous manner. It has been demonstrated under IFN-γ 
stimulation conditions that five of the known IRG proteins were concentrated very 
fast at the parasitophorous vacuoles (PVs) in T.gondii infected primary astrocytes 
(Martens et al., 2005) or various of other cell types (Hunn and Könen-Waisman 
unpublished results). Parasites labeled by IRG proteins then underwent disruption 
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probably due to vesiculation of the PV membrane and consequent exposure of the 
parasite to the cytosol (Martens et al., 2005). Our data add primary hepatocytes to the 
list of cell types which can control T.gondii growth by stimulation with IFN-γ (Fig. 
18). The behavior of IFN-γ-induced IRG proteins in infected cells, including 
accumulation to the PV membrane, hierarchy of PV coating by different IRG family 
members is essentially the same as observed in primary astrocytes (Martens et al., 
2005); Könen-Waisman unpublished results) (Fig. 19&20&21). This reinforces the 
argument that accumulation of IRG GTPases onto the T.gondii vacuoles is a common 
resistance mechanism shared by cells under stimulation of IFN-γ in vivo. To our great 
interest, in freshly isolated primary hepatocytes constitutively expressed Irga6 was 
able to accumulate at the T.gondii vacuoles in the absence of IFN-γ, though a smaller 
portion of T.gondii vacuoles was coated than under IFN-γ stimulated conditions (Fig. 
19). Obviously, tissue-specifically expressed Irga6 is able to launch a similar 
anti-T.gondii program as in IFN-γ-induced cells. This observation further strengthens 
our speculation that the preexistence of IRG proteins, which are normally highly 
induced upon infection, in an immune suppression environment like liver would be 
advantageous for host resistance to various intracellular pathogens which may make 
use of this immune privileged milieu. Surprisingly, no other IRG proteins could be 
detected at T.gondii vacuoles, although most of them showed considerable level of 
expression in primary hepaocytes (Fig. 20). For this, we do no have an explanation 
yet, nevertheless one plausible reason could be that it is a stoichiometrical effect. 
Given the fact that the presence of GMS proteins is essential for correct localization 
and activation of GKS proteins (Hunn unpublished results), the low expression level 
observed for some IRG members such as Irgm3 in primary hepatocytes (Fig. 16), is 
likely to contribute to the lower efficiency of GKS protein accumulation at T.gondii 
vacuoles in comparison to the optimal situation of IFN-γ-induction.  
 
4.4 IRG proteins are constitutively expressed in many other tissues 
The constitutive expression of Irgm3 gene in mouse tissues such as thymus, spleen, 
small intestine and lung was reported in a non-quantitative way (Taylor et al., 1996), 
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and the protein expression of Irgm3 and Irgd in thymus and spleen was subsequently 
detected (Collazo et al., 2001). In line with these observations, in our quantitative 
analysis, Irga6 protein also exhibited significant constitutive expression in thymus and 
spleen, and to lesser extence in skin, intestine, lung, kidney and testis (Fig. 10). 
Nevertheless, the expression levels of Irga6 in these tissues were incomparable to that 
in the liver. Irga6 was expressed at a high level in the heart as well. No IRG protein 
expression could be found in brain. In the case of Irgm3, however, the expression in 
tissues other than liver was hardly detectable using western blot. Only under highly 
over-exposed conditions, Irgm3 protein expression could be detected, which shared 
the similar expression profile as Irga6 (Fig. 10).  
The expression of Irga6 in heart is not very much affected in IFN receptor deficient 
mice. This recalls the Irga6 expression in liver driven by a hepatocyte specific 
promoter. However in contrast to liver, where, the ratio of liver-specific Irga6 1B 
transcript to 1A is up to 100, in heart 1A form is 5 times more abundant than 1B form, 
in addition to the fact that the absolute expression level of Irga6 1B is scores of times 
higher than that in the heart (Parvanova, Ph.D thesis). Furthermore Irga6 in heart is 
not ubiquitously expressed which is not similar to that in liver, rather only in certain 
cardiac myocytes (Fig. 11). These observations are not in favor of the argument that 
Irga6 expression in heart is also controlled by a heart-specific promoter which should 
promote an overall expression of only one form of transcript.  
Irga6 is expressed in spleen, thymus, skin and intestine in an IFN-dependent manner 
(Fig. 12). For spleen and thymus developmentally regulated bursts of IFN synthesis 
may contribute to the expression of IRG proteins in these organs, since a constitutive 
expression of Irga6 was also reported in hematopoietic stem cells (Terskikh et al., 
2001; Venezia et al., 2004). Skin and intestine are constantly exposed to external 
microbial environment as well as other immune stimuli such as lesions. Therefore it 
may be that local IFN bursts in responses to such unexpected stimulations induce the 
expression of IRG proteins. This hypothesis can be tested by examining germ-free 
mice. 
The weak expression of Irga6 in kidney turned out to exist in a focal pattern (Fig. 11). 
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This focal expression similar to that in liver (Fig. 8&9) is dependent on IFNs, which 
will be discussed in more detail later. 
 
4.5 Irga6 focal expression in liver and kidney exploits interferon pathway 
Immunohistochemical staining of liver always showed a general expression of Irga6 
in hepatocytes, and in addition exceptional intense focal expression also in 
hepatocytes (Fig. 22). In kidney though Irga6 is not expressed ubiquitously, the focal 
expression of Irga6 appears very similar to that in liver (Fig. 11). Through the genetic 
analysis of IFN signaling pathway, it turned out that focal expression in both liver and 
kidney represents local IFN activation (Fig. 24, 25 and 26). This argument was further 
strengthened by the detection of coexpression of Irgm3 in Irga6 expression foci both 
in liver and kidney (Fig. 23).  
The IFN signaling pathway starts from binding of IFNs to corresponding receptors on 
the cell surface. All IFN-α/β subtypes interact with the same receptor complex, termed 
the IFN-α/β receptor (IFNAR) and IFN-γ binds to the IFN-γ receptor complex 
(IFNGR) (Bach et al., 1997; Darnell et al., 1994; Stark et al., 1998; Uze et al., 1990). 
The binding of both types of IFNs to IFNAR or IFNGR results in the cross-activation 
of these Jak protein kinases, which then phosphorylate their downstream substrates, 
Stat1 and Stat2 (signal transducers and activators of transcription) (Darnell et al., 
1994; Ihle and Kerr, 1995; Schindler and Darnell, 1995; Stark et al., 1998), causing 
the formation of STAT1-STAT2 heterodimers for type I IFNs, and STAT1 
homodimers for IFN-γ. Thereafter, STAT1-STAT2 heterodimers associate with a third 
protein, IRF9, and bind one class of type I IFN response elements, the ISRE, whereas 
STAT1 homodimers activate gene expression by binding to another class of IFN 
response elements, the GAS (Bluyssen et al., 1996; Darnell et al., 1994; Decker et al., 
1991; Haque and Williams, 1994; Lew et al., 1991). Type III IFN signaling is very 
similar to that of tpye I IFN (Kotenko et al., 2003; Sheppard et al., 2003; Vilcek, 
2003). 
Therefore, STAT1 is essential for both all types of IFN signaling, and STAT1 deficient 
mice are unresponsive to all types of IFN (Durbin et al., 1996; Meraz et al., 1996). 
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Our data showed that the focal expression of Irga6 in liver and kidney from STAT1 
deficient mice was completely abolished (Fig. 26), strongly suggesting the local 
induction of Irga6 by IFNs. This argument was reinforced by the observation that 
Irga6 1A form, which is driven by an IFN-inducible promoter, is much more abundant 
in the expression foci than non-foci in liver (Fig. 30).  
Immunohistochemical staining of liver sections establishes two types of Irga6 focal 
expression. One type is represented by a group of liver parenchymal cells, which 
express much higher amounts of Irga6 than the surrounding cells forming clear-cut 
boundaries and take the shape of patches. The other kind of focal expression exhibits 
exactly the same features except that they always have in the center a group of small 
mononuclear cells, which are Irga6 negative. Those mononuclear cells have small 
condensed nuclei and few cytoplasm, characteristic of lymphocytes or leukocytes (Fig. 
22).  
Among the two types of focal expression of Irga6 in liver, only cored patch 
expression was abolished in IFN-γ knock out mice (Fig. 24), implying an 
IFN-γ-induced expression of Irga6 in cored patches. Demonstration of the existence 
of IFN-γ within the ‘cores’ of cored patches but not in the patches without cores (Fig. 
32) further established the role of IFN-γ as the inducer of Irga6 local expression in 
cored patches. In the case of Irga6 expression patch without cores, atthough no direct 
evidence is available, it is extremely likely that this type of expression is induced by 
type I IFN, since it is dependent on STAT1 signaling but obviously not IFN-γ.  
The origin of focal expression of Irga6 in kidney is somehow baffling, since it is 
dependent on both type I and II IFN receptors, implying a dual control from both 
types of IFN. It is well acknowledged that type I IFN signaling can cross talk with the 
signaling of type II IFN (Takaoka et al., 2000). One interpretation is therefore that 
type I IFN is required to synergize the activation of type II IFN to achieve an optimal 
focal induction of Irga6 in kidney. A very recent report demonstrated that stimulated 
myeloid dendritic cells (DCs) were able to activate NKT cells to produce IFN-γ 
(Paget et al., 2007). Furthermore, this process was dependent on type I IFN synthesis 
in dendritic cells as well as de novo production of glycosphingolipid of DCs. In view 
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of the fact that NKT cells are the major activators in the cored patch expression of 
Irga6 in liver, it is a plausible argument that activation of NKT cells in a type I IFN 
dependent manner is the cause of the Irga6 expression foci in kidney.  
 
4.6 NKT cell activation in Irga6 cored expression patch in liver  
Unlike type I IFN, which theoretically can be produced by almost all types of cells, 
the capacity of IFN-γ production is normally limited to a few types of 
immunocompetent cells such as activated NK cells and activated subsets of T cells 
(Mosmann and Coffman, 1989; Perussia, 1991; Sad et al., 1995). The small 
mononuclear cells in the cores of Irga6 expression patchs are perfect candidates for 
IFN-γ secretion. Indeed, we demonstrated cells with macrophage and T cell markers 
in the center of the cored expression patch of Irga6 in liver (Fig. 33), and the 
indispensability of T cells for the formation of Irga6 cored patches was also 
demonstrated by examining T cell deficient mice (Fig. 34). This requirement of a 
functional immune system is in line with the fact that, unlike the overall constitutive 
expression in liver, which is lauched already in neonatal mice and persists constantly 
high later on, the focal expression is hardly detectable in the post neonatal mice and 
the number of foci rises to a constant level from three weeks on. This correlates well 
with the development of the immune system of neonatal mice, which have T cells 
with limited capacity of cytokine production right after birth (Riley, 1998).  
A systematic analysis of T cell receptor repertoire used by T cells in the cores of Irga6 
patches revealed that NKT cells are most likely the major T cell subset responsible for 
the local IFN-γ activity in liver. NKT cells are defined as a T cell lineage expressing 
NK lineage receptors, in addition to semi-invariant CD1d-restricted αβ TCRs. More 
than 80% of these TCRs are Vα14-Jα18/Vβ8, Vβ7, and Vβ2 in mouse (or 
Vα24-Jα18/Vβ11 in human), and the remaining are Vα3.2-Jα9/Vβ8, Vα8/Vβ8, and 
other TCRs (Cardell et al., 1995; Park et al., 2001). Among the three Vβ segments 
used by Vα14-Jα18 NKT cells, Vβ8 (mainly Vβ8.2) is predominantly employed at a 
proportion of more than 50% (Bendelac et al., 1994; Lantz and Bendelac, 1994). In 
view of the fact that non-Vα14-Jα18 NKT cells mainly make use of Vβ8 segment as 
                                                   Discussion 
 101
well, a biased usage of Vβ8 by NKT cells is apparently consistent. Our data showed 
that T cells in the cores of Irga6 expression patches carried only TCR Vβ8 
(predominantly Vβ8.2) (Fig. 35). Furthermore, all the Vα14 TCR carried by T cells in 
the cores of Irga6 expression patches only employed the Vα14-Jα18 junction, while 
the TCR Vα11, which was an unspecific product in the attempt to amplify Vα14 from 
the peripheral T cells displayed a variety of junctional variations (Fig. 38 and 39). The 
Vα14-Jα18 junction described here actually was also polyclonal but with only a few 
substitution right at the junction between Vα14 and Jα18. This narrowly defined 
junction for T cells in the cores of Irga6 patches, compared to its highly variable 
counterpart for peripheral T cells implies a highly selective clustering of a specific 
subset of T cells in the cores of Irga6 expression foci. TCR Vα14 has been reported 
not being frequently used by peripheral T cells (Yoshida et al., 2000a), which is rather 
consistent with our observation. However, TCR Vα14 was very abundantly used by T 
cells in the cores of Irga6 expression foci in comparison to other Vα family members. 
Taken together, these observations demonstrate that Vα14-Jα18/Vβ8 NKT cells are 
the near exclusive population of T cells in the cores of Irga6 expression foci in liver. 
In Irga6 cored patches Vα8 could also be found at a relatively lower level (Fig. 40), 
suggesting the presence of non-Vα14-Jα18 NKT cells in the cores.  
NKT cells are activated upon presentation of their ligands by dendritic cells (DCs) 
and secrete IL4 and IFN-γ, which probably also requires type I IFN secretion by DCs. 
A following reciprocal activation of NKT cells and DCs can in turn enhance NKT cell 
activation and cytokine production (Kitamura et al., 1999; Tomura et al., 1999). 
Propagation of this reaction involves the activation of NK cell cytolysis and IFN-γ 
production (Carnaud et al., 1999; Eberl and MacDonald, 2000) and priming of robust 
adaptive immune responses (Fujii et al., 2004; Fujii et al., 2003; 
Gonzalez-Aseguinolaza et al., 2002). In view of the fact that cytokine secretion esp. 
that of IFN-γ is characteristic of NKT cells activation, the IFN-γ dependent Irga6 
expression foci with cores enriched in NKT cells, are very likely to represent local 
activation of NKT cells in liver. This argument is reinforced by our observation that 
TLR signaling is not essential for the Irga6 cored patch formation (Fig. 42 and 43) 
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since TLR signaling is shown not to be involved in the direct NKT cell activation via 
its ligand representation (Bendelac et al., 2007). In the mouse the liver is the organ 
most enriched in NKT cells, making up 30% of the local T cell population (Matsuda 
et al., 2000). NKT cells normally patrol the liver sinusoids through CXCR6/CXCL16 
interaction to provide immune surveillance (Geissmann et al., 2005). Furthermore, 
NKT cells stop patrolling and become fixed upon TCR activation (Geissmann et al., 
2005). Hence it is tempting to imagine that, when NKT cells are activated locally in 
liver, chemokines and cytokines such as IFN-α/β and IFN-γ are produced, which in 
turn recruit leukocytes like macrophages, NK cells and probably more NKT cells to 
aggregate and to produce even more IFN-γ, which subsequently induces the 
expression of Irga6 in the hepatocytes around. The direct involvement of NKT cells in 
this process need to be further clarified for instance by CD1d-Gal:Cer tetramer 
labeling of NKT cell in the cores of Irga6 expression and by examining CD1d- or 
β-hexosaminidase-B-deficient mice, both of which are devoid of NKT cells (Coles et 
al., 2000; Zhou et al., 2004).  
 
4.7 What are the causes of local NKT cell activation? 
The causes of local NKT cell activation in the liver remain elusive. It is known that 
NKT cells are activated when their TCR are engaged by their ligands loaded on 
MHC-like antigen presentation molecule, CD1d (Bendelac et al., 2007).  
α-GalCer, a glycosphingolipid derived from marine sponges, is a strong agonist ligand 
that can initiate NKT cell-dependent immune response, leading to enhanced immunity 
to tumors and infectious organisms and suppression of certain autoimmune diseases 
(Godfrey et al., 2004; Joyce et al., 1998). The activation of NKT cells by marine 
sponge α-GalCer obviously lacks direct physiological relevance. Recently closely 
related structures that substitute for LPS have been discovered in the cell wall of 
Sphingomonas, a Gram-negative, LPS-negative member of α-proteobacteria 
(Kawahara et al., 2000; Kawasaki et al., 1994). These sphingolipids can strongly 
stimulate NKT cells, which leads to the clearing of the infection (Kinjo et al., 2005; 
Mattner et al., 2005; Wu et al., 2005). Our data showing unaltered Irga6 focal 
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expression patterns in germ-free mice rule out the possibility of such an activation of 
NKT cells by bacterial sphingolipid in a microbial environment (Fig. 41).  
Three years ago, a report from Zhou et al. offered strong evidence that 
isoglobotrihexosylceramide (iGb3), a mammalian glycosphingolipid (GSL) produced 
for cellular membrane sphingolipids, is an endogenous CD1d-dependent agonist for 
NKT cells from mice and humans (Zhou et al., 2004). It is known that endogenous 
lipid ligands are involved in a stage of positive selection at which the endogenous 
ligand presentation by CD1d expressed on double positive T cells in the thymic cortex 
is indispensable (Wei et al., 2005). In this report, it was showed that 
β-hexosaminidase-B (Hexb-/-) deficient mice, which lack the ability to degrade iGb4 
into iGb3 in the lysosome, had a great decrease in thymic NKT cell production, and of 
the known degradation products resulting from the activity of these enzymes, only 
(iGb3) showed in vitro stimulatory activity toward iNKT cells (Zhou et al., 2004). 
Therefore, it was concluded that iGb3 is the endogenous ligand mediating positive 
selection of iNKT cells in the thymus. A subsequent study using an iGb3-blocking 
lectin then implicated iGb3 in peripheral activation of iNKT cells by dendritic cells 
(DCs) (Mattner et al., 2005). However, the role of iGb3 as an endogenous CD1d lipid 
ligand determining thymic NKT cell selection has recently been challenged by the 
latest report demonstrating that mice deficient in mice deficient in iGb3 synthase and 
consequently totally lacking iGb3, have normal NKT cell development (Porubsky et 
al., 2007). The authors argued that other GSLs instead of iGb3 may serve as 
physiological selecting ligands in vivo since the NKT cell loss is not specific to 
Hexb-/- mice but rather a general property of other mouse models of glycosphingolipid 
storage disorder (Gadola et al., 2006; Sagiv et al., 2006). The consensus, however, 
that the interactions between NKT cell TCR and endogenous sphingolipid ligands in 
CD1d expressing bone marrow-derived cells in thymus is essential for NKT cell 
thymic differentiation, is not changed, since both thymic CD1d and intact glycolipid 
lysosomal degradation and storage are crucial for the normal selection of NKT cells in 
thymus (Gadola et al., 2006; Wei et al., 2005). In thymus positively selected NKT cell 
precursors undergo several round of division and acquire an effector phenotype and 
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then migrate to periphery (Pellicci et al., 2002; Stetson et al., 2003). It was proposed 
that, in peripheral tissues the effector status of NKT cells characterized by their 
explosive cytokine release upon TCR stimulation (Yoshimoto and Paul, 1994) and 
their basal low-level transcription of cytokine genes (Stetson et al., 2003) must be 
maintained by repeated TCR engagement presumably by their endogenous ligands 
presented by CD1d. In line with this hypothesis, CD1d is not only expressed by 
antigen presenting cells but also strikingly on cells like Kupffer cells, sinusoid 
endothelial cells and hepatocytes in mice liver, where the highest frequencies of NKT 
cells are found in mice (Geissmann et al., 2005). Surprisingly however, CD1d is not 
required for survival and effector phenotype maintenance of terminally differentiated 
NKT cells (Matsuda et al., 2002; Wei et al., 2005). In view of the fact that the Irga6 
expression foci also exist normally in germ-free mice, which have been shown to have 
unaltered NKT cell distribution and effector phenotype (Park et al., 2000), it is 
tantalizing to speculate that the Irga6 expression foci represent a continuous process 
of local activation of NKT cells in order to maintain an effector phenotype. The 
involvement of CD1d in this local activation of NKT cells could be tested by 
examining mice that have normal NKT cell thymic development but are deficient in 
CD1d in liver or kidney.  
 
4.8. Where does Irga6 focal expression without cores originate? 
The origin of Irga6 expression foci without cores remains mysterious. Why there are 
local type I IFN activities independent of the presence of lymphocytes and also in the 
absence of microbial environment? One possibility is local responses to virus 
infection since germ-free mice are not completely virus-free. Virtually all cell types 
are able to produce IFN-α/β in response to viral exposure. The most efficient producer 
of IFN-α, however, is one of two principle subsets of dendritic cells, Plasmacytoid 
dendritic cell (pDC) (Fitzgerald-Bocarsly et al., 1988). IFN-α/β are produced by 
pDCs in response to a wide range of enveloped viruses, including herpes simplex 
virus (HSV), human immunodeficiency virus type I (HIV-1), influenza viruses etc. 
(Coccia et al., 2004; Jarrossay et al., 2001), as well as parasites (Plasmodium 
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falciparum) (Pichyangkul et al., 2004), bacteria (e.g. SAC) (Svensson et al., 1996). 
Although TLRs esp. TLR 7 and 9 that are expressed by pDCs (Hemmi et al., 2002; 
Krug et al., 2001) and MyD88 are demonstrated to be involved in the activation and 
the IFN-α/β production of pDCs in response to viruses, MyD88 independent pathways 
leading to IFN-α production by pDCs have also been described (Tabeta et al., 2004). 
The MyD88 independent Irga6 focal expression without cores (Fig. 43) may represent 
the local activation of pDCs and the consequent production of type I IFN by pDCs.  
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5. Summary 
 
Immunity-related GTPases (IRG) are essential, interferon-inducible resistant factors 
in mice that are actively against a broad spectrum of important intracellular pathogens. 
IRGs are represented by 25 genes in the mouse and also in almost all mammals and 
many other vertebrates, but surprisingly not in human. Structurally IRGs all share 
canonical GTP-binding domains and the crystal structure of one representative family 
member, Irga6, possesses an H-Ras-1-like GTP-binding domain. The biochemical 
properties of Irga6 are reminiscent of dynamins. Though the resistance mechanisms 
are still obscure, there is growing evidence supporting the role of IRG proteins as 
cell-autonomous resistant factors most probably through their direct targeting to 
intracellular pathogen-containing membrane compartments.  
IRGs are expressed under the tight regulation of IFNs. We found in this work 
unexpectedly that IRG proteins do have significant constitutive as well as 
IFN-induced expression in vivo. In liver at least for one member of IRG, Irga6, this 
differential expression is achieved by alternative activation of a liver-specific 
promoter and an IFN-inducible promoter. The constitutively expressed Irga6 in the 
presence of other constitutively expressed IRG proteins in primary hepatocytes is able 
to launch a similar anti-T.gondii program as IFN-induced protein, implying the role of 
IRG proteins as sentinel in the resistance against intracellular pathogens in liver that is 
an organ of immune privilege. Peculiar Irga6 focal expression in liver as well as in 
kidney is also observed and proved to be induced by local production of IFNs. This 
production of IFN-γ that induces Irga6 focal expression in liver surprisingly 
represents the local activation of NKT cells even in the absence of microbial 
environment (germ-free mice). Even though the causes of this NKT cell activation are 
still elusive, we speculate that this stimulation of NKT cells may stand for an ongoing 
process required for the maintenance of the effector status for peripheral NKT cells.  
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Zusammenfassung 
 
Interferon- induzierbare IRGs (immunity- related GTPases) spielen eine bedeutende 
Rolle als Resistenzfaktoren in Mäusen gegen ein breites Spektrum intrazellulärer 
Parasiten. In der Maus kodieren 25 Gene für IRGs, ebenso lassen sie sich in fast allen 
Säugern sowie in vielen anderen Vertebraten finden, erstaunlicherweise jedoch nicht 
im Menschen. Strukturell teilen sich alle IRGs eine konservierte GTP- 
Bindungsdomäne, diese zeigt bei einem  Vetreter der Proteinfamilie, Irga6, eine 
H-Ras-1- gleiche Kristallstruktur. Ihrer biochemischen Eigenschaften nach erinnert 
Irga6 an Dynamine. Obwohl die Abwehrmechanismen immer noch nicht genau 
bekannt sind, mehren sich die Anzeichen welche für eine Funktion der IRG- Proteine 
als zellautonome Resistenzfaktoren, wahrscheinlich über eine direkte Lokalisation an 
die Membran intrazellulärer pathogenhaltiger Kompartimente, sprechen.  
Die Expression der IRGs unterliegt der Regulation durch IFNs. Überraschenderweise 
fanden wir im Zuge dieser Arbeit heraus, dass IRG- Proteine sowohl ein signifikante 
konstitutive wie auch eine IFN- induzierte Expression zeigen. Diese unterschiedliche 
Expression wird z.B. in der Leber für zumindest ein IRG- Mitglied, Irga6, dadurch 
erreicht, das alternativ ein leberspezifischer Promoter oder ein IFN- induzierbarer 
Promoter aktiviert wird. Konstitutiv exprimiertes Irga6, in Anwesenheit weiterer 
konstitutiv exprimierter IRG- Proteine, vermag in primären Hepatocyten ein 
vergleichbares anti- T.gondii- Programm zu starten wie die IFN- induzierten Proteine, 
und deutet darauf hin, dass die konstitutiv exprimierten IRG Proteine in der 
immunprivilegierten Leber einen jederzeit verfügbaren Resistenz Mechanismus 
bilden. Charakteristische  fokale Irga6- Expression ist in der Leber wie auch in den 
Nieren zu beobachten und auf lokale Produktion von Interferonen zurück zu führen. 
Diese durch die Produktion von IFN-g induzierte fokale Epression in der Leber 
spiegelt erstaunlicherweise genau die lokale Aktivierung von NKT- Zellen wieder, 
selbst in Abwesenheit eines mikrobiellen Umfelds (keimfreie Mäuse). Obwohl die 
Gründe für diese Aktivierung von NKT- Zellen noch schwer nachvollziehbar sind, 
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vermuten wir dass diese Stimulation von NKT- Zellen vieleicht einen fortlaufenden 
Prozess darstellt und dass dieser benötigt wird um den Effektorzustand für periphere 
NKT- Zellen aufrecht zu erhalten. 
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